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ABSTRACT 
 Ischemic stroke is a major world-wide health problem, resulting in death and 
disability especially in the older population. A sex difference exists in functional recovery 
post-stroke, with post-menopausal women having worse functional outcome as 
compared to age-matched men. Although the mechanisms underlying this sex difference 
are not entirely clear, it is recommended that any potential therapy for stroke recovery be 
tested in pre-clinical models including both male and females in order to determine the 
efficacy of the proposed treatment on the entire population. We have reported a novel 
therapy to enhance brain plasticity and improve functional recovery after stroke in aged 
male rats by neutralizing the neurite inhibitory protein Nogo-A. We now propose to 
determine the efficacy of this treatment on synaptic proteins important for neural 
connectivity and functional recovery. We hypothesized that post-stroke sensorimotor 
recovery is worse in the aged female rat due to a decrease in synaptic proteins that are 
necessary for neuronal connectivity and this can be improved with anti-Nogo-A 
immunotherapy. We tested this hypothesis in the following specific aims. Specific Aim #1 
determined sex differences in synaptic proteins in aged male and female rats post-stroke 
in the contralesional forelimb motor cortex using viral vectors to label cortical pyramidal 
neurons and high resolution confocal microscopy to examine synaptic proteins. Stroke 
was found to decrease excitatory synapse number, except in OVX females, who were 
already at a low number. Specific Aim #2 determined sex differences in aged male and 
female rats in synaptic plasticity that have been treated post-stroke with anti-Nogo-A 
immunotherapy and examined three weeks later for synaptic protein changes. The 
overall goal of this aim was to determine if anti-Nogo-A immunotherapy is useful in 
improving post-stroke synaptic changes in aged rats, thereby improving our 
  
  
xv 
understanding and therapeutic approach to this devastating condition. It was shown that 
anti-Nogo-A immunotherapy increased excitatory number in males and intact females, 
but not OVX females. Specific Aim #3 determined sex differences in aged male and 
female rats post-stroke using behavioral tests of skilled sensorimotor function and 
examined dendritic profiles of pyramidal layer V motor neurons using Golgi-Cox stain. It 
was shown that while males learned the forelimb reaching task slower than both female 
groups, they had a better post-stroke recovery. Females had the largest decrease in 
dendritic complexity (pre-stroke they had the highest complexity). In conclusion, it has 
been shown that there is a sex difference in terms of excitatory synapse number 
following stroke and a sex difference with regard to post-stroke recovery. Anti-Nogo-A 
immunotherapy was shown to have a sex steroid-dependent effect and this could have 
far-reaching implications for post-menopausal women receiving the therapy. 
  
  
 
CHAPTER ONE 
OVERVIEW AND HYPOTHESIS 
 Stroke is a debilitating disorder that affects millions worldwide each year in both 
deaths and disability (Bushnell et al., 2014). The risk for stroke increases with age, as 
does the possibility of lasting neurologic damage (Bushnell et al., 2014). Stroke severity 
is also dependent on sex, as post-menopausal women have worse functional outcome 
post-stroke compared to age-matched men (Bushnell 2006; Bushnell 2008). With 
menopause being the turning point for functional recovery following stroke (Bailey et al., 
2011; Bartoli et al., 2013), the mechanisms underlying stroke recovery (and its resulting 
sex differences) are paramount to uncover. Due to the large number of stroke victims, 
the increased risk of stroke with age, and the sex differences involved in stroke recovery, 
an in-depth study into those differences and underlying brain plasticity is warranted. 
 While treatments for stroke are rare, a novel therapeutic is anti-Nogo-A 
immunotherapy which is directed against Nogo-A, a myelin-associated growth inhibitor 
of both axons and dendrites (Schwab et al., 2014). It has been shown in our lab that 
anti-Nogo-A immunotherapy following focal cortical stroke resulted in improved 
performance in the skilled forelimb reaching task (Papadapoulos et al., 2002; Markus et 
al., 2005; Tsai et al., 2011). This research found a correlation between axonal and 
dendritic plasticity in the contralesional cortex with functional recovery following stroke. 
The contralesional cortex is considered an area of therapeutic value because new 
connections will be sent to the damaged hemisphere through the corpus collosum from 
there. While this past research has focused on male rats, experiments with female rats
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 are recommended now by the National Institutes of Health in order to better meet the 
appropriate experimental model.  
Synaptic changes have also not been fully investigated, especially with regard to 
cortical connections to the area damaged by a middle cerebral artery occlusion (e.g. the 
forelimb motor cortex). These excitatory synaptic connections in the motor cortex play a 
role in motor movement for the entire body and as such are crucial to recovery of 
movement after stroke. 
                                                      HYPOTHESIS 
Post-stroke sensorimotor recovery is worse in the aged female rat due to a 
decrease in synaptic proteins in the contralesional motor cortex and this synaptic 
number can be improved with anti-Nogo-A immunotherapy 
Specific Aim 1: To determine sex differences in synaptic proteins in aged male 
and female rats post-stroke in layer V pyramidal neurons in the contralesional 
forelimb sensorimotor cortex. 
Rats will be divided into the following groups: aged males, aged intact females, and 
aged OVX females. At time of MCAO stroke, rats will be injected with AAV2/8-CMV-
GFP-LDL-RCT in their contralesional motor cortex to label layer V pyramidal neurons. 
After 3 and 8 weeks, brains will be processed by immunohistochemistry for co-
localization of NMDAR-NR1, VGLUT1/2 and pre-labeled viral AAV2/8-CMV-GFP-LDL-
RCT neurons (on the dendrite), and synaptic counts will be quantified using confocal 
imaging.  
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Specific Aim 2: To determine sex differences in aged male and female rats in 
synaptic proteins in layer V pyramidal neurons in the contralesional forelimb 
motor cortex that have been treated post-stroke with anti-Nogo-A immunotherapy. 
Rats will be divided into the following groups: aged males, aged intact females, and 
aged OVX females. At time of MCAO stroke, rats will be injected with AAV2/8-CMV-
GFP-LDL-RCT in their contralesional motor cortex to label layer V pyramidal neurons. 
Rats will receive either anti-Nogo-A immunotherapy (11C7) or control antibody by 
intracerebroventricular (ICV) mini-osmotic pump into the lateral cerebral ventricle. Rats 
will be sacrificed at 3 weeks post-stroke for synaptic protein analysis, as in Aim 1. 
Specific Aim 3: To determine sex differences in aged male and female rats post-
stroke using behavioral tests of skilled sensorimotor function. 
Pre-stroke, rats will be trained to perform the skilled forelimb reaching task and the 
skilled ladder rung walk task. They then will undergo middle cerebral artery occlusion 
(MCAO) on the side corresponding to the preferred forelimb and then will be tested for 8 
weeks post-stroke on these skilled sensorimotor tasks. 
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CHAPTER TWO 
REVIEW OF LITERATURE 
STROKE 
 Stroke is a common and debilitating disorder resulting in 140 million US deaths 
and many more disabilities each year (Bushnell et al., 2014).  A stroke can be one of 
several types. Ischemic is the most common (approximately 79%) and occurs when a 
blood vessel supplying an area of the brain is blocked or impeded, depriving that brain 
region of oxygenated blood (Egido and de Lecinana, 2007; Lang and McCullough, 
2008). Hemorrhagic stroke is the less common of stroke variants. Hemorrhagic stroke 
occurs when the brain is deprived of blood through an occluded artery in which the 
occluded area becomes filled with blood from necrotic and degenerating vessels (Moore 
and Daley, 1999). A direct hemorrhage can also occur such as under the arachnoid 
meningeal layer (subarachnoid hemorrhage) (Moore and Daley, 1999; Buma et al., 
2013).  
          The middle cerebral artery (MCA) plays a crucial role in supplying the cerebrum 
(parietal, frontal and temporal lobes) (Moore and Daley, 1999) (Figure 1) with 
oxygenated blood. The MCA has a branch on both sides of the brain and arises from the 
internal carotid and continues into the lateral sulcus (Moore and Daley, 1999; Buitrago et 
al., 2004). It is also connected to the anterior cerebral arteries and posterior 
communicating arteries while not directly being a part of the Circle of Willis (Moore and 
Daley, 1999). Occlusion of the MCA can have dramatic effects (depending on what part 
of the brain is occluded), such as weakness or paralysis of the contralateral face, arm, 
and leg, sensory loss of the contralateral face, arm, and leg, as well as aphasia, neglect 
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syndrome, and depression (Bradnam et al., 2013; Buma et al., 2013; Cheng et al., 
2013). This loss of brain tissue has an impact on the outcome of the patient depending 
on what area of the brain was damaged, such as limb strength and sensation being 
affected by the opposite side middle cerebral artery occlusion (Kamal and Iadecola, 
2012; Taylor and Sansing, 2013; Garcia-Bonilla et al., 2014). 
 
 
Figure 1.  Brain Artery Perfusion Areas in the Human. Of note is the perfusion of the 
motor cortex by the middle cerebral artery, along with major fiber pathways. From 
Blumenfield Anatomy, 2002. ACA: Anterior Cerebral Artery; MCA: Middle Cerebral 
Artery; PCA: Posterior Cerebral Artery. 
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 No matter the cause, a stroke results in damaged neural tissue due to toxin build-
up and apoptosis and necrosis, along with oxidative stress and mitochondrial 
dysfunction (Kamal and Iadecola, 2012; Guesuete et al., 2014; Petrone et al., 2014) 
leading to cell death and immune responses. Apoptosis (Figure 2) in that area begins 
quickly as energy is depleted and wastes build up (Kamal and Iadecola, 2012; Guesuete 
et al., 2014). During a stroke the immune system also plays a role, with invasion by T 
cells and activated microglia (Brait et al., 2012; Xu et al., 2013) releasing inflammatory 
cytokines (Lambertsen et al., 2012; Shichita et al., 2012) and pro-apoptotic signals 
(Kamal and Iadecola, 2012; Taylor and Sansing, 2013; Garcia-Bonilla et al., 2014) with 
activation of microglia, and invasion of monocytes and leukocytes (Petrone et al., 2014). 
 Tissue plasminogen activator (tPA) is currently the only approved post-stroke 
pharmaceutical treatment, but must be administered in the early stage and carries risks 
of worsening of the stroke due to hemorrhaging (Moore and Daley, 1999). Many people 
are not eligible for this treatment since they will not be admitted to a hospital in that short 
time window and only seven percent of stroke patients receive it (Del Zoppo et al., 
2009). Rehabilitation currently remains the main post-stroke treatment, with focuses on 
regaining lost ability and possibly stimulating new brain connections to either repair or 
compensate for damaged tissue (Wahl and Schwab; 2014; Wahl et al., 2014). 
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Figure 2. Apoptotic Pathways. Shown here are the cellular pathways starting at 
ischemic damage (lack of oxygen, build-up of toxins, excitotoxicity) and leading to 
apoptosis through oxidative damage and free radicals as well as apoptosome formation. 
Ischemia results in increased extracellular glutamate due to release and lack of 
reuptake, causing NMDA receptors to let in calcium. This increased intracellular calcium 
can activate calpains which in turn activate Bid. Bid binds to the mitochondrial 
membrane and allows Cytochrome C to exit (CytC) which activates caspases and 
apoptosis. From Broughton et al., 2009. PARP: Poly-ADP Ribose Polymerase.
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Stroke has been shown to increase in both risk and mortality with increase in age 
(Brown et al., 2003; Merret et al., 2010), but the underlying mechanisms have yet to be 
elucidated. The increased risk in stroke due to age has been postulated to be due to 
vascular changes that deteriorate over time and are dependent on the health of the 
individual (Bayer and Hausman, 2011). Other factors such as increased vessel plaque, 
atherosclerosis, and increased risk for embolisms are also postulated. It has been 
shown in mice that age results in decreased white matter and increased damage 
following stroke (Suenaga et al., 2015). Of particular interest to this study is the change 
in sex hormones and receptors, seen both in female (Cai et al., 2014) and male (Wu and 
Gore, 2010) animal models that occur with aging. Aging increases stroke damage and 
affects the sexes differently (Liu and McCullough, 2012). An older (post-menopausal) 
woman affected by stroke is at an increased risk of death and disability following stroke 
(Bushnell, 2006; Bushnell, 2008). 
NEUROLOGICAL SEX DIFFERENCES IN RODENTS AND HUMANS 
 There are many neurological sex differences, especially in the human brain. 
These differences could be used to explain the differences in stroke risk and recovery. 
Of particular note is the size, with males of both human and rat brains having a larger 
weight, although it is proportional to increased body weight of males in both species 
(Zaidi, 2010). Men have been found to have more gray matter, while women have more 
white matter (Zaidi, 2010). Of interest to this study is the corpus callosum, which is larger 
in women and does not change much with age (Ardekani et al., 2012). Astrocytes are in 
a higher number in females and react to damage differently (Chisholm and Sohrabji, 
2015) with estrogen decreasing the astroglial scar (Chisholm and Sohrabji, 2015). Also 
of interest is that Broca’s and Wernicke’s Areas are significantly larger in women (Zaidi, 
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2010). While these anatomical differences have not been studied in detail in the rat 
brain, cellular mechanisms have been better studied. 
 There are sex differences in regard to cellular mechanisms. Males have higher 
brain estrogen receptor concentrations (Ritzel et al., 2013). The G-protein-coupled 
estrogen receptor (GPER) is upregulated in male rats more than females following 
ischemia (Broughton et al., 2013a, Broughton et al., 2013b). Females also have 
decreased inflammation compared to males (Manwani et al., 2013), especially in regards 
to ischemic inflammation (Ritzel et al., 2013; Zuo et al., 2013). Apoptosis has been 
shown to be decreased with increased estradiol concentrations (Lang and McCullough, 
2008). Estradiol has also been shown to facilitate synthesis of progesterone in 
astrocytes (Wong et al., 2013) and astrocytes express the progesterone receptor (Wong 
et al., 2013). Estradiol and progesterone have been shown to decrease astrocyte 
proliferation following injury, even in aged animals (Wong et al., 2013). The circulating 
levels of progesterone that rise during the rat estrous cycle and the human menstrual 
cycle could also have neuroprotective effects similar to estradiol. While male rats and 
human men also have detectable progesterone levels (Amador et al., 1985), it is not as 
high a level as their female counterparts (MacBeth et al., 2007; Acosta et al., 2009). The 
sex differences in levels of estradiol, progesterone, and other sex hormones contributes 
to a different response to aging, injury and recovery. Mechanisms for these 
aforementioned hormones will be discussed in detail later. 
 Also of importance is that many psychological disorders have a sex bias to them, 
with women having increased risk for major depression, borderline personality disorder, 
and generalized anxiety disorder (Loke et al., 2015) all of which depend on brain 
dysfunction. Some psychological disorders have no sex bias to them, such as obsessive 
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compulsive disorder (Loke et al., 2015) while others have similar rates yet different 
timing (e.g. women typically develop schizophrenia earlier than men) (Loke et al., 2015). 
SEX DIFFERENCES IN ISCHEMIC STROKE AND RECOVERY 
Stroke is a leading cause of death and disability worldwide, especially in the 
aged population (Alkayed et al., 1999; Lewis et al., 2012), where mortality is different in 
males (5th leading cause of death) and females (3rd leading cause of death) (Bushnell et 
al., 2014). Incidence of stroke is also higher in aged females than males (Bushnell et al., 
2014). Recovery post-stroke also differs between the sexes with post-menopausal 
women recovering worse than age-matched men (Bushnell 2008; Liu et al., 2009; Kim et 
al., 2010; Bushnell et al., 2014). Such trends will rise considering more people are 
expected to live longer, with women now living a larger portion of their lives post-
menopausal (Manwani et al., 2013). Risk of death and worse recovery from stroke in 
females rises after menopause and may be related to the reduction in estrogens as they 
are thought to be neuroprotective (Miller et al., 2005; Dang et al., 2011; Liu et al., 2009; 
Soderstrom et al., 2009).  
Based on these findings in humans, it has been proposed that female rats be 
used when studying recovery from stroke in addition to male animals, as it is believed 
that sex differences could exist. In fact, the National Institutes of Health (NIH) has 
strongly suggested that age-appropriate female animals be included when studying 
stroke recovery or therapeutic agents to improve recovery. Earlier research has shown 
that a sex difference does indeed exist when studying animal models of cerebrovascular 
disease (Wu et al., 2005; Zuo et al., 2013). Of particular interest to this study are the sex 
differences in sex hormone receptors, such as the G-protein-coupled estrogen receptor 
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(GPER). This receptor has been shown to have different effects in males and females 
(Broughton et al., 2013b). It is also more upregulated in male rats following stroke 
(Broughton et al., 2013a). The presence (and lack thereof following menopause) of 
estradiol has been shown to affect hippocampal aging (Han et al., 2013), infarct damage 
(McEwen and Alves, 1999; Garcia-Segura et al., 2001; Manwani and McCullough, 
2012), inflammation (Petrone et al., 2014) and the insulin-like growth factor 1 (IGF-1) 
receptor and signaling cascade (Sohrabji, 2014). The last is of interest due to the 
interplay of estrogen’s modulation of IGF-1’s Akt up-regulation and decrease in 
apoptosis (Sohrabji, 2014). These examples illustrate the necessity of a female model to 
examine potential sex differences in stroke recovery and other studies.  
There are psycho-social reasons why stroke recovery could be worse in females. 
Although not proven, it is suggested that of the reasons why aged women do not recover 
as well as aged men is that there exists decreased social links with aged women and 
social support (Bushnell, 2006; Bushnell, 2008). There is also an increased risk of 
needing longer hospital stay time and mental institutionalization, all of which have a 
bearing on, and are a barrier to, recovery (Bushnell, 2006; Bushnell, 2008; Bushnell et 
al., 2014). It is also proposed that women may live longer than their social links and 
outlive them, resulting in a diminished set of social links and support (Persky et al., 
2010). Better recovery could occur with increased social support, such as through joining 
an exercise group (Persky et al., 2010; Bushnell et al., 2014). All these factors can 
contribute to the apparent sex difference in stroke recovery.  
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NEURONAL CONNECTIVITY, SYNAPTIC PROTEINS, AND SEX STEROIDS 
Although many proteins are responsible for synaptic connectivity (Baudry et al., 
2013; MacLusky, 2013; Kramer et al., 2013), of particular note are the NMDA receptors, 
as they are responsible for spine growth and signal transduction (Minano et al., 2008). 
NMDA receptors are heterotetramer channel proteins activated by glutamtate, D-serine, 
and glycine (Minano et al., 2008). Agonist binding along with membrane depolarization 
from AMPA receptors (which removes a magnesium plug) allows for NMDA receptors to 
open and let in sodium and calcium, depolarizing the post-synaptic cell (Minano et al., 
2008). NMDA receptors are the post-synaptic components of most CNS excitatory 
signaling (Minano et al., 2008; Kaneko, 2013). The subunits of the heterotetrameric 
NMDA receptor include NR1, necessary to bind glutamate (Minano et al., 2008; Kaneko, 
2013), along with NR2 and NR3. NR1 is included in every functional NMDA receptor due 
to the fact that glutamate does not bind without it (Minano et al., 2008). 
Also of note is the post-synaptic density 95 (PSD95) protein, found in dendrites 
and spines which serves to anchor receptors to the post-synaptic membrane (Minano et 
al., 2008; Baudry et al., 2013) (Figure 3). Loss of these or other synaptic proteins leads 
to a decrease in neuronal connectivity and communication and can lead to loss or 
diminished function in associated brain regions. Estradiol has been shown to increase 
protein expression of the synaptic proteins PSD95 and NMDA-NR1 in young animal 
models (Norbury et al., 2003; Baudry et al., 2013), but has yet to be examined in aged 
female rats or after stroke in the aged female rat. Estradiol also increases expression of 
cytoskeletal proteins (Norbury et al., 2003; Baudry et al., 2013), which play a role in 
dendritic and spine formation (Hao et al., 2006; Sato et al. 2007). Estradiol has also 
been shown to promote long term potentiation and spine maturation by increasing the 
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number of AMPA receptors present on spines and by promoting actin polymerization 
(Kramer et al., 2013). 
           The vesicular glutamate transporter proteins (VGLUT) are of importance in the 
vesicular storage and reuptake of glutamate (through excitatory amino acid transporter), 
as this is the main way of terminating its (usually) excitatory signaling (Baudry et al., 
2013; MacLusky, 2013; Kramer et al., 2013) (Figure 4). The subtypes of VGLUT include 
VGLUT 1 and 2, which have been found to be localized to the pre-synaptic membranes 
of cortico-cortical and thalamo-cortical connections, respectively (Kaneko, 2013). They 
are also found in astrocytes. Other subtypes of VGLUT can be found in astrocytes and 
other neurons (Kaneko, 2013), but are also located near the synapse.
 
Figure 3. Post-synaptic Density 95 Anchors the NMDAR. PSD95 is shown here 
anchoring the NMDAR to the post-synaptic membrane. mGLUR = metabotropic 
glutamate receptor; GKAP = guanylate kinase-associated protein; FMRP = fragile X 
mental retardation protein. From State, 2010.  
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Figure 4. Glutamate in the Synapse. NMDAR as well as other glutamate receptors 
receive neurotransmitters released from the pre-synaptic cell while glutamate is taken 
back up by a glutamate transporter and is packaged into vesicles using vesicular 
glutamate transporter. From Atwell and Gibb, 2005. 
 
 
 
 
 
 
 
  15 
 
Spine and dendrite morphology have been shown to play a key role in learning 
and behavioral function (Phan et al., 2012; Brocca et al., 2013). Estradiol has been 
shown to increase spine number (Foy et al., 2008) as well as increase long-term 
potentiation and decrease long-term depression involved with those spines (Foy et al., 
2008; Kramar et al., 2013). Estradiol has been shown to trigger actin polymerization in 
spines (Kramar et al., 2013). It is also of note that long-term depression occurs more in 
aged rodents, which is further exacerbated by stress (Foy et al., 2008). Estradiol shares 
its synapse-inducing effects along with progesterone (Rivera and Bethea, 2012). Several 
reports have also pointed to estradiol’s ability to either induce or synergize synapse 
function and growth alongside neurotrophins (Schnell et al., 1994; Scharfman and 
MacLusky, 2006; Srivasta et al., 2013). Synapses are also sensitive to growth inhibitory 
factors (discussed in detail later) with Nogo-A as an identified antagonist (Xiao et al., 
2012; Ritzel et al., 2013; Zemmar et al., 2014). There are numerous reports of 
decreases in spine density following ovariectomy, especially in the hippocampus and 
pre-frontal cortex (Velazquez-Zamora et al., 2012). 
While spines have been shown to have the potential to be transient (Holtmaat et 
al., 2005) (Figure 5), there are many that are more permanent (Holtmaat et al., 2005). 
Spines are subject to pruning or strengthening based on experience and learning 
(Holtmaat et al., 2006; Holtmaat and Svoboda, 2009). Estrogen has been shown to be a 
modifier of spine growth and stability (Foy et al., 2008), especially due to the synaptic 
proteins that it up-regulates (Norbury et al., 2003; Baudry et al., 2013) as well as 
maintaining mature spines longer (Kramar et al., 2013). 
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Figure 5. Dendritic Spine Plasticity. Shown here is the spine formation and actin 
dynamics required for it. From Hotulainen and Hoogenraad, 2010. 
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Estradiol is considered the most potent of the estrogens, being able to bind to the 
three main estrogen receptors with equal affinity (estrogen receptor alpha (ERA), 
estrogen receptor beta (ERB) (Morissette et al., 2008) and the G-protein-coupled 
estrogen receptor (GPER, formally known as GPR30) (McAllister et al., 2012; 
Schreihofer and Ma, 2013; Arevalo et al., 2014; Lamprecht and Morrison, 2014). It is 
also the main hormone released from the ovaries during the ovulatory cycle and has a 
large decrease in production during menopause (Wise and Dubal, 2000; Cheskis et al., 
2007). In the rat model, menopause as seen in humans does not take place, but a type 
of ‘reproductive senescence’ occurs after approximately one year of age in which sex 
steroids no longer cycle but instead exist at a low basal level and fertilization is 
uncommon (Baeza et al., 2010). The other estrogens, estrone and estriol, do not bind as 
well as estradiol to the estrogen receptors and are present in higher concentrations 
during menopause (McClure et al., 2013).  
Two mechanisms of estrogen signaling are the ‘fast’ versus ‘slow’ routes of 
action. Slow routes include activation of transcription or transcription (through binding 
directly to the DNA’s estrogen response element (ERE)) of transcription factors. The 
GPER pathway calls for a faster mode of action, in which cellular events occur more 
rapidly than through transcription (Srivastava and Penzes, 2011; Srivastava et al., 2011). 
This utilizes the phosphoinositide 3-kinase activation by a membrane-bound estrogen 
receptor (Wu et al., 2005) that leads to activation of Bcl-2 and inhibition of apoptosis (Wu 
et al., 2005). Much of this research into a non-genomic route of action has focused on 
the newest of the estrogen receptors, GPER (formally GPR30 from its orphan receptor 
naming) (Hazell et al., 2009). GPER is activated by estradiol, causing activation of the 
Gαs subunit and activation of adenylyl cyclase with an increase in cAMP for quick 
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activation of protein kinase A (PKA) (Hazell et al., 2009). The general consensus seems 
to point to a combination of slow and fast mechanisms (Kramar et al., 2013), with a 
further postulation that estradiol may transactivate the TrkB receptor and promote spine 
growth through BDNF signaling (Kramar et al., 2013). BDNF also uses the Rho GTPase 
signaling pathway (Kramer et al., 2013) and depending on the cellular location this may 
cause an intersecting of estradiol, BDNF, and Nogo signaling (as described in more 
detail below). Estradiol has also been shown to upregulate aquaporin 4 levels leading to 
reduced edema following stroke (Shin et al., 2011). It has been shown that stroke itself 
does not affect measureable serum levels of estradiol (Shin et al., 2011) (Figure 8).  
Although there is an increased risk for cancer (such as breast or ovary) with 
exogenous estradiol treatment (Petrone et al., 2014), the use of selective estrogen 
receptor modulators has grown. Some only activate ER-beta and are less likely to cause 
cancer (Petrone et al., 2014). Further clinical trials are needed, however, for their 
approved treatment usage. Timing is also an important issue in hormone treatments. 
Of particular note is the ability of neurons and glia cells to produce sex steroids 
de novo from cholesterol, creating ‘neurosteroids’ (Raz et al., 2008; Wise et al., 2009; 
Rettberg et al., 2014). It has been shown that both neurons and astrocytes express 
aromatase as well as the estrogen receptors (Wise et al., 2009; Azcoitia et al., 2011; 
Brann et al., 2012) (Figure 6). ER alpha and beta are expressed by most cells, with ER 
beta having the higher expression in the motor cortex and hippocampus (Wise et al., 
2009; Azcoitia et al., 2011; Brann et al., 2012), though ER alpha has been shown to be 
up-regulated immediately following ischemic stroke (Wise et al., 2009) (Figure 7). 
Currently being researched are the specific interactions estradiol has with its receptors, 
which are proposed to be used for neuroprotection or neural repair. ERB has been 
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proposed to be protective (Raval et al., 2013) while the effect is dependent on the 
dosage given (Strom et al., 2011), with too little or too much being considered 
detrimental (Strom et al., 2011). It has been shown in experimental studies that cerebral 
blood flow is not dependent on estradiol during ischemic stroke (Wang et al., 1998; Dang 
et al., 2011).  
A crucial point of the Women’s Health Initiative (WHI) study was the discovery of 
the ‘window of opportunity’ hypothesis, in which exogenous estradiol treatment must be 
begun within a very short window following natural or surgical menopause (Liu and 
Yang, 2013). While the timing is hypothesized to vary by individual, it has been 
suggested that hormone replacement therapy begin as soon as possible (Liu and Yang, 
2013). Therapy beginning after the ‘window’ is believed to have caused the increased 
risk of stroke and cardiovascular disease seen in the WHI and elsewhere (Murphy et al., 
2004; Nagasaki et al., 2013). Dosage, type of estrogen, timing, duration of treatment and 
age of participants were all determining factors in the WHI study (Murphy et al., 2004; 
Nagasaki et al., 2013). It has been shown that the type of estrogen is important, such as 
estradiol having more positive effects than estrone (McClure et al., 2013). Estrone is at a 
high level following menopause (McClure et al., 2013) but the ratio of each estrogen in 
the body can be altered by the estrogen interconversion enzymes (17beta-
hydroxysteroid dehydrogenases) (McClure et al., 2013). 
Of interest to this dissertation is the use of the ovariectomy model (OVX) which 
we have observed to cause a decrease in circulating estradiol concentrations. This 
mimics the loss of estradiol that occurs during human female menopause (Bushnell et 
al., 2014). This model, like all models, does not exactly mimic the human condition. A 
positive is that the surgery is a relatively simple procedure with quick recovery and 
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depletion of endogenous estradiol while a negative is that it does not perfectly model a 
woman’s slow decline of estradiol during menopause. Another method used to study 
menopause in animal models is the use of the follicular toxin 4-Vinylcyclohexene 
Diepoxide (VCD). This toxin is injection daily in order to induce death of the ovarian 
follicles over time, resulting in their loss and the estradiol they produce (Hoyer et al., 
2001; Kappeler and Hoyer, 2012). This model more accurately represents the follicular 
degeneration seen in women but is toxin-based, which is unlike human menopause and 
could be toxic elsewhere in the body.  
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Figure 6. Steroid Synthesis. Shown here is the neurosteroids (and general synthesis) 
pathways of transforming cholesterol into progesterone, estradiol, and testosterone. 
Arom = aromatase, HSD = hydroxysteroid dehydrogenase, StAR = Steroidogenic acute 
regulatory protein. From Wang, 2011. 
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Figure 7. Estradiol Receptors. Shown here is the ability of estrogen to bind to ER-
alpha, ER-beta, or the endoplasmic reticulum-located GPR30 (also known as GPER). 
From Weatherman, 2006. 
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Figure 8. Estradiol Slow and Fast Routes. Shown here are the potential downstream 
pathways that estradiol (E2) along with excitatory neurotransmitter channels (AMPAR 
and NMDAR) and how anti-apoptotic and new synapse proteins can be transcribed 
(slow). There are also faster routes in which kinases are activated quickly to affect 
downstream proteins. Of note are the usage of calcium and the PI3K pathway. From Wu 
et al., 2005. 
Along with estradiol (Gibson et al., 2006), progesterone is the other main 
hormone produced by the ovaries and affected by menopause (Harsh et al., 2009; Liu et 
al., 2014). Progesterone’s action is directly affected by estradiol, as estradiol causes up-
regulation of some progesterone receptors (Sorwell and Urbanski, 2013; Liu et al., 
2014). Progesterone’s affects in the brain are similar to estradiol’s, such as increasing 
dendritic spine number and increasing growth factor expression (Rehman and Masson, 
2005; Hoffman et. al, 2006), with an on-going discussion as to its effects following 
menopause. While some authors show a non-beneficial response to progesterone 
therapy (usually given alongside estrogen), there are others that show positive or mixed 
results depending on the report (Hoffman et. al, 2006; Lee et al., 2010; Liu and 
McCullough, 2012; Liu et al., 2014) (Figure 9). Progesterone has been shown to 
increase spine number, especially through PSD95 transcription (de Castilhos et al., 
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2008; Rivera and Bethea, 2012; Sanchez et al., 2013; Rivera and Bethea, 2013). In 
terms of injury, progesterone has also been shown to decrease inflammation (Wong et 
al., 2013), decrease astrocyte proliferation following injury (Wong et al., 2013), and 
significantly decrease lesion volume (Wong et al., 2013). Progesterone has been shown 
to decrease Nogo-A and glial fibrillary acidic protein (a marker of glial cells) while 
increasing growth-associated protein 43 levels (Liu et al., 2014). It has been shown in 
the literature that progesterone levels are present in both aged rat sexes (Figure 10). 
Therefore, the literature has shown that progesterone has many neuroprotective 
qualities similar to estradiol. 
Further under investigation are the effects of exogenous sex hormones given as 
treatment or preventative care. Examples include estrogens (in either estradiol form or 
conjugated equine estrogen (CEE) form) and progesterone, which may impact other 
neurological systems, such as mood (Backstrom et al., 2013). While still being 
investigated, this shows the wide range of targets and effects of sex hormones.  
Following stroke, the levels of sex hormones could potentially change as brain 
anatomy is altered. This depends on the location of the stroke. A stroke infarct to the 
hypothalamus or pituitary could alter levels of sex hormone-releasing hormones 
(luteinizing hormone and follicle stimulating hormone). Middle cerebral artery occlusion 
has been shown to temporarily increase aromatase and estrogen receptor alpha 
(Alkayed et al., 1995). Other groups have shown that stroke decreases total serum 
testosterone and free serum testosterone, but not estradiol (Jeppesen et al., 1996). It 
has also been shown in both male and female rats that there is no change in estradiol 
following stroke (Shin et al., 2011). 
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Figure 9. Progesterone Signaling. Shown here are the progesterone (P4) signaling 
pathways through the progesterone receptor (PR) (either cytosolic or membrane-bound 
(mPR)) and the possible mechanisms of neuroprotection through genomic and non-
genomic brain-derived neurotrophic factor (BDNF). Suggested here is that progesterone 
can have differing effects if it binds to a cytosolic receptor (leading to increased BDNF 
transcription) or if it binds to a membrane receptor (which could decrease BDNF 
transcription) From Singh et al., 2013. 
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 18 m.o. male rat 18 m.o. female rat 18 m.o. OVX female 
rat 
Estradiol 3.9pg/mL (Bimonte-
Nelson et al., 2008) 
56.7 pg/mL 
(Borkowski et al.) 
10pg/mL (Bimonte-
Nelson et al., 2008) 
N/D (Borkowski et 
al.) 
5pg/mL (Markowska 
and Savonenko, 
2002) 
Testosterone 2.8ng/mL (Amador et 
al., 1985) 
1 ng/mL (Bimonte-
Nelson et al., 2008) 
13.29pg/mL 
(MacBeth et al., 
2007) 
N/D (Acosta et al. 
2009) 
Progesterone 0.5 ng/mL (Amador et 
al., 1985) 
13.71pg/mL 
(MacBeth et al., 
2007) 
1pg/mL (Acosta et 
al. 2009) 
 
Figure 10. Hormone Levels. List of aged (18 month-old (m.o.)) rat levels of the three 
main sex hormones: estradiol, testosterone, and progesterone (N/D = Non-determinable 
or below assay detection level). 
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Testosterone is also a major sex hormone, especially in males. It can be 
aromatized to estradiol or bind to its own androgen receptors (Wu et al., 2005). 
Testosterone has been shown to be pro-growth in that in a similar fashion to estradiol it 
binds to its receptors which then act as transcription factors. This allows for the 
transcription of similar genes to estradiol (Chen et al., 2013). Testosterone has been 
shown to increase dendrites and spine number as well as be neuroprotective (Chen et 
al., 2013; Wu and Gore, 2010). Testosterone is also present in smaller concentrations in 
aged female rats (MacBeth et al., 2007). Female rats (as well as humans) are believed 
to have different concentrations and distributions of androgen receptors than males 
which may impact testosterone signaling. 
NOGO-A AND GROWTH INHIBITORY FACTORS 
Nogo-A is an inhibitory protein expressed on the surface of oligodendrocytes and in the 
myelin that they produce in the central nervous system, but can also be found in some 
neurons (Caroni & Schwab, 1988a; Caroni & Schwab, 1988b; Chen et al., 2000; Dodd et 
al., 2005; Papadopoulos et al., 2006; Cheatwood et al., 2008).  Two extracellular regions 
of the Nogo-A protein have been attributed to axonal growth inhibition (see Figure 11). 
This is accomplished through disruption of neurite growth cones (Wang et al., 2002) and 
by limiting angiogenesis (Walchi et al., 2013).  The extracellular regions contain the 
inhibitory domains Nogo-66 and delta-20, near the N-terminal portion.  Nogo-66 is a 66-
amino acid sequence that is common to all the isoforms of Nogo, while Nogo-A544-725 is 
Nogo-A specific (Caroni & Schwab, 1988a; Caroni & Schwab, 1988b). Neutralization of 
Nogo-A’s inhibitory domains by treatment with monoclonal antibodies (mAB) have been 
a long-term interest in our group to promote axonal outgrowth in the treatment of CNS 
injuries (Papadopoulos et al., 2002; Markus et al., 2005; Tsai et al., 2011).   
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The existence of Nogo and other growth inhibitory factors has been known for 
some time (McKerracher et al., 1994; Kawamata et al., 1997), but has only recently been 
better characterized (Kempf and Schwab, 2013). Along with Nogo-A, many other growth 
inhibitory factors exist, such as paired immunoglobin-like receptor B (PirB), 
oligodendrocyte-myelin glycoprotein (OMgp), and myelin associated glycoprotein (MAG), 
along with extracellular matrix proteins such as proteoglycans (Filbin, 2003; Buss et al., 
2005; Cafferty et al., 2010). OMgp and MAG, along with Nogo-A, can be found on 
oligodendrocytes and act in a similar manner to Nogo-A by binding to and activating 
cellular receptors which can result in growth inhibition (Bongiorno and Petratos, 2010; 
Schwab et al., 2014). PirB acts in a similar manner to Nogo-A’s receptors with similar 
downstream pathways (Filbin, 2003; Schwab et al., 2006). 
GROWTH INHIBITION CELLULAR MECHANISMS 
 Nogo-A can bind to two different receptors, with different portions of the molecule 
binding. The delta-20 region has been shown to bind to the sphingosine-1-phosphate 
receptor 2 (S1PR2) (along with potential interactions with integrins) (Kempf et al., 2014). 
It is to this portion of Nogo-A (also called ‘amino Nogo’) that the antibody 11C7 binds 
(Tsai et al., 2007; Bongiorno and Petratos, 2010). The Nogo-66 region binds to the 
Nogo-66 Receptor (NgR1) as well as PirB (Chivatakarn et al., 2007; Schwab, 2010; 
Borrie et al., 2012). Binding to either of these receptors leads to a still poorly understood 
downstream mechanism, but which is believed to activate the Rho A GTPase which in 
turn activates Rho-associated, coiled-coil containing protein kinase (ROCK), a serine 
kinase (Kramar et al., 2013). This inhibits myosin light chain phosphatase (MLCP) 
causing a ‘stabilization’ of the growth cone actin, resulting in inhibited movement as actin 
cycling is arrested (Schwab, 2010; Fujita and Yamashita, 2014). This also has been 
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shown to inhibit the phosphorylation and deactivation of cofilin, destabilizing actin 
polymers to form monomers (Kramar et al., 2013). This process has also been shown to 
be dependent on protein synthesis (Manns et al., 2014) and several labs have shown 
other pathways induced by Nogo-A but ultimately resulting in RhoA activation 
(Schweigreiter et al., 2004; Yan et al., 2012) (Figure 12). 
 Of interest to this dissertation are the findings that growth inhibitory factors may 
have a sex difference associated with them. It has been shown that neuronal S1PR2 is 
expressed more in female brains (Cruz-Orengo et al., 2014). If this were the case then a 
higher expression may mean more growth inhibition in females. Also of interest is the 
fact that the RhoA pathway in which Nogo and its receptors use to halt the growth cone’s 
growth (Schwab and Strittmatter, 2014) is also used by estradiol to cause actin 
polymerization from monomers (Kramar et al., 2013) as well as BDNF to stimulate spine 
growth (Kramar et al., 2013). Possible future directions may look at the complex 
intersection of these three pathways. The sex differences are especially highlighted 
when looking at data that suggests that estradiol activates the RhoA pathway as well 
(Kramar et al., 2013) but in a positive manner of inhibiting cofilin allowing actin 
monomers to form into filaments (Kramar et al., 2013). 
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Figure 11. Nogo-A Signaling.  Nogo-A is a transmembrane protein expressed primarily 
by oligodendrocytes.  The amino portion of the protein, labeled here as “Δ20,” is unique 
to Nogo-A, and is not found on either Nogo-B or Nogo-C.  It is this portion of the protein 
bound by the specific antibodies used in these experiments. Using an antibody specific 
for Δ20 keeps Nogo-A from binding to its receptor, thereby allowing for axonal and 
dendritic plasticity after CNS injury. Shown here are the downstream proteins following 
receptor binding, starting with S1PR2’s G-protein (G13) which activates RhoA to activate 
it. RhoA then activates ROCK (From Schwab and Strittmatter, 2014). 
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Figure 12. Nogo-A and Sex Hormones. Summary of the proposed mechanics of Nogo-
A leading to growth cone stalling and collapse through S1PR2 and NgR1 to the RhoA 
pathway alongside possible interaction with estradiol (E2) membrane-bound and 
cytosolic receptors (Adapted from Wu et al., 2005; Kramer et al., 2013; Schwab and 
Strittmatter, 2014). P4: progesterone, T: testosterone, ROCK: Rho-associated coiled-coil 
kinase. MLCP: myosin light chain phosphatase. 
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ANTI-NOGO-A IMMUNOTHERAPY AND NEURONAL PLASTICITY FOLLOWING 
CNS INJURY 
 It was discovered in 1988 that antibody-mediated neutralization of the reticulon 
family proteins (of which Nogo-A is a member) could lead to increased growth of 
damaged and severed axons and neurites (Caroni and Schwab, 1988a; Caroni and 
Schwab, 1988b; Mukhopadhay et al., 1994). This was further expounded by Schwab 
and colleagues in which mature oligodendrocytes were inhibitive of this growth (Caroni 
and Schwab, 1988a). A monoclonal antibody was then raised against isolated 
membrane-bound proteins (Caroni and Schwab, 1988b; Schnell and Schwab, 1990). 
Later identification of this protein led to the title of Nogo-A (Chen et al., 2000). 
The Nogo gene has three different splice variants (Nogo-A, -B, and –C) (Chen et 
al., 2000; Grandpre and Strittmatter, 2001) (Figure 13). In the Nogo-A protein there are 
two active sites of particular note for CNS recovery: Amino-Nogo, which binds to the 
Sphingosine-1-Phosphate Receptor (S1PR2) and the Nogo-66 region near the C-
terminal domain which also induces growth cone collapse through binding to the Nogo-
66 Receptor (NgR1) and PirB Receptor (Chen et al., 2000; Schwab, 2004; Schwab, 
2010). 
          Our laboratory has shown that anti-Nogo-A immunotherapy enhanced new axonal 
growth from uninjured pathways that projected to areas denervated by a CNS lesion 
(Kartje et al., 1999; Wenk et al., 1999; Seymour et al., 2005).  Furthermore, our lab has 
reported extensively on the administration of anti-Nogo-A antibodies which resulted in 
axonal plasticity of intact fiber tracts and brain reorganization (Kartje et al., 1999; Wenk 
et al., 1999; Emerick and Kartje, 2004; Emerick et al., 2005; Papadapoulos et al. 2006), 
and most significantly improved functional recovery of skilled forelimb movements in 
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adult and aged male rats post-stroke (Papadopoulos et al., 2002; Markus et al., 2005; 
Tsai et al., 2007; Gillani et al., 2010). The efficacy of anti-Nogo-A immunotherapy in 
stroke impaired aged female rats is an important area of investigation since females 
recover worse than males post-stroke and may respond differently to this therapeutic 
intervention.  
 
Figure 13. The Nogo-A Gene. This schematic shows the two active growth-inhibiting 
sites of Nogo-A and their targets (Amino Nogo and Nogo-66) with target receptors 
(Amino-Nogo-A receptor now reported to be the S1PR), effects and antibody binding 
locations. From Schwab et al., 2006.   
 
NOGO-A IN CLINICAL TRIALS 
 The Nogo-A protein has been of potential clinical value for some time (Pernet 
and Schwab, 2012; Wang et al., 2012; Schwab and Strittmatter, 2014). Phase 1 clinical 
trials for ALS and multiple sclerosis are underway using the antibody named 
Ozanezumab through GlaxoSmithKline (Meinenger et al., 2014). Novartis earlier 
completed Phase 1 of a spinal cord injury trial using a similar antibody (Clinical Trials 
Identifier: NCT00406016) in 2011.  
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NOGO AND PSYCHIATRIC DISORDERS 
Nogo-A levels have been seen altered in psychiatric disorders (Novak and Tallerico, 
2006). Nogo-A has been shown to be implicated in several disorders, including rat 
models of schizophrenia (Willi and Schwab, 2013). Nogo-A’s growth inhibition may play 
a role in impeding normal mental function as particular brain connections are reduced or 
inhibited. This theory has been put forward for many mental disorders including 
schizophrenia but also major depression, antisocial personality disorder, and autism 
(Willi and Schwab, 2013; Schmandke et al., 2014). While more research is needed on 
the subject, it is apparent Nogo-A has widespread effects not just on axonal and 
dendritic plasticity leading to sensorimotor recovery but also on higher-level functioning. 
Of particular note are the other roles Nogo has in normal animals and neural 
development, such as the reduced motivational behaviors seen in rats with reduced 
Nogo-A (Enkel et al., 2014). Transgenic rats with reduced Nogo-A showed deficits in 
cognition along with decreased anxiety and a change in circadian rhythms (Petrasek et 
al., 2014). This shows another reason why Nogo-A cannot be removed completely from 
the central nervous system. 
BEHAVIORAL TASKS FOR LEARNING AND FUNCTIONAL RECOVERY 
Measuring behavioral recovery from stroke has a long history in research and 
many tasks exist depending on which aspect of recovery is desired to be measured. Of 
interest to this dissertation is the skilled forelimb reaching task, developed by Castro and 
Whishaw (Castro, 1972) and the skilled ladder rung walking task, as developed by Metz 
(Metz and Whishaw, 2002). Usefulness of these tasks lies in their ability to be accurate, 
quantifiable, and translatable to human motor movements, such as in the fine grasping 
task of the skilled forelimb reaching and skilled ladder rung walking task. These tasks 
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have been used to measure cortical brain injuries and the extent of the behavioral deficit 
after cortical injuries (Papadapoulos et al., 2002; Papadapoulos et al., 2006; Tsai et al., 
2007). 
In addition, the use of behavioral tests to measure learning (particularly in the 
hippocampus) is widespread. Of interest to this dissertation are motor tasks for 
measuring age-related changes. This has been studied using nuclear magnetic 
resonance imaging (NMRI) studies in mice (with aged animals learning slower than 
younger animals) (Lamberty and Gower, 1992). These learning tasks also involve a 
change in the motor cortex possibly resulting from increased use and increased cortical 
connectivity (Kami et al., 1998) which is an area of research not yet fully investigated. 
CORTICAL CONNECTIVITY 
The neocortex is defined by its many layers and connections. Studying these 
connections can make it possible to study behavioral changes due to injury. There are 
six neocortical layers, with differing cell types in each. Layer I (the molecular layer) is 
mostly apical dendrites and glial cells. Layer II (the external granular layer) has small 
pyramidal neurons. Layer III (the external pyramidal layer) has small and medium 
pyramidal neurons. Layer IV (the internal granular layer) also contains pyramidal 
neurons. Layer V (the internal pyramidal layer) has large pyramidal cells and is the start 
of the corticospinal tract. The axons from these neurons form the large cortico-efferent 
descending pathways, including the cortico-spinal tract and the cortico-rubral tract. Layer 
VI (the multiform layer) has smaller pyramidal cells and multiform neurons and connects 
mainly to the thalamus (Markowska and Savonenko, 2002) (Figure 14). Of interest to 
this dissertation are the connections to and from the pyramidal layer V forelimb motor 
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cortex, as this is where voluntary motor movement is generated. Damage to this area 
results in forelimb reaching deficits (Markus et al., 2005; Tsai et al., 2007). Therefore, 
cortical connectivity is important to study as it dictates motor planning and movement 
and has a large impact on behavior. 
One of the major connections to the layer V pyramidal neuron are the afferent 
signals from the thalamus, specifically the VA/VL nuclei of the thalamus used in motor 
movement (Yu et al., 2008; Kaneko, 2013). These are usually excitatory and release 
glutamate onto the post-synaptic receptors, such as AMPA receptors and NMDA 
receptors (Yu et al., 2008; Kaneko, 2013). The released glutamate is taken up by the 
vesicular glutamate 2 transporter (VGLUT2) (Kaneko, 2013). These connections are 
important because they communicate with part of the basal ganglia, in which motor 
movement is controlled and fine-tuned. Parkinson’s Disease is an example of a deficit in 
this layer (Huang et al., 2015). 
The other major connections to the layer V pyramidal neuron are from other 
layers, or even the same layer of the cortex itself (Kaneko, 2013). This can be from 
layers of the same hemisphere or from the contralateral hemisphere (traveling through 
the corpus callosum) (Yu et al., 2008; Huang et al., 2015). The excitatory signal is also 
glutamate onto the same receptors listed above (AMPA and NMDA receptors). After 
release, glutatmate is re-taken up by excitatory amino acid transporters and returned to 
vesicles via the vesicular glutamate 1 transporter (Hira et al., 2013; Kaneko, 2013). 
These signals can also be inhibitory using vasoactive intestinal peptide or gamma 
aminobutyric acid (Tanaka et al., 2011; Kaneko, 2013).   
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The motor cortex sends signals outwards to the contralateral motor cortex, 
striatum, globus pallidus, and spinal cord through the corticospinal tract and other 
structures (Yu et al., 2008; Huang et al., 2015). It is through these pathways that motor 
movement is initiated, inhibited, or dis-inhibited along with input from the cerebellum (Pi 
et al., 2013). Each hemisphere connects to each other through the corpus callosum (Yu 
et al., 2008) and this cross-talk is an important factor in motor recovery when one 
hemisphere is damaged (Papadapoulos et al., 2006). 
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Figure 14. Neocortex Connectivity and Layers. The pyramidal cells can be seen in 
layers III, V and VI and their respective synapses, such as from the thalamus and from 
other neocortex areas. Adapted from The Thalamus and Cerebral Cortex (Integrative 
Systems) Part 1 Tutorial (What-When-How). 
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The focus of this dissertation is the repair of the cortex following an injury such as 
stroke and the resulting new synapses that are formed or re-formed. The rubro-spinal 
tract, for example, has been shown to be able to re-form cortical connections following a 
stroke (Takenobu et al., 2014) and it has been shown that there is a crossing of the 
fibers at the level of the red nucleus from the intact hemisphere to the de-enervated red 
nucleus following stroke and anti-Nogo-A immunotherapy (Papadapoulos et al., 2002; 
Papadapoulos et al., 2006). Our laboratory has also shown that there is a significant 
number of fibers crossing over from the uninjured cortex to innervate the de-enervated 
subcortical structures such as the striatum, spinal cord, pons and red nucleus 
(Papadapoulos et al., 2002; Markus et al., 2005; Papadapoulos et al., 2005; Tsai et al., 
2007). This has shown that the uninjured contralesional cortex is a potential site for 
neural repair and functional recovery following injury. 
Projections from the cortex were shown to be at least partially recoverable even 
in the absence of treatment (Carmichael, 2003; Jiang et al., 2013). It has been 
suggested that the large portions of the cortex reorganizes its connections following a 
stroke (Grefkes and Ward, 2014; Starkey and Schwab, 2014) which can be postulated to 
be the neurons working around the infarct and glial scar to recreate those previous 
connective pathways spontaneously, though to a limited effect (Wieloch and Nikolich, 
2006). Aging itself results in neuronal changes (Heuninckx, et al., 2008), especially in 
cortical connections (Thouvarecq et al., 2007; Del Zoppo, 2012). The combination of 
aging and injury could result in a different reorganization that may not be effective 
(Nudo, 2013) and has been shown to affect dendrites and axons in different ways 
(Mizielinska et al., 2009). While the motor cortex has been shown to have defined areas 
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and connections (Neafsey et al., 1986) it has been proposed that the resulting brain 
repair could result in a changed but effective model (Small et al., 2013).
886 
 
 
CHAPTER THREE 
SEX DIFFERENCES IN SYNAPSE NUMBER IN THE RAT FORELIMB MOTOR 
CORTEX 
ABSTRACT 
Sex-based differences in recovery from stroke are an area of research not yet fully 
explored. This is especially true with regard to aged rats’ excitatory synapse number in 
the motor cortex, which model human post-stroke functional recovery and synaptic 
connections. In the human clinical population, post-menopausal females have been 
shown to recover from stroke less successfully than age-matched males. Therefore, 
studying sex differences in rat models of stroke recovery is clinically relevant. We set 
out to determine if differences in excitatory synaptic number were evident in the 
different sexes, which may influence recovery from stroke and connectivity relating to 
motor movements and recovery. 18 month-old Fischer 344 male and female aged rats 
were used for these studies. Rats were divided into three groups: ovariectomized (OVX) 
females, intact females, and age-matched males. Half of each group received a stroke 
and half did not. All rats received adeno-associated virus (AAV2/8-CMV-GFP-LDL-
RCT) injections to the motor cortex to pre-label cortico-efferent pyramidal neurons in 
layer V. At the end of three or eight weeks, rats were sacrificed for 
immunohistochemistry to quantify excitatory synapses in pyramidal layer V forelimb 
motor cortex. Neurons that were GFP-positive with a typical pyramidal shape and good 
dendritic labeling were identified via confocal microscopy. Using 630x oil magnification, 
basilar dendrites were examined for presynaptic (vGlut1 or vGlut2) markers and co-
localization with the postsynaptic marker NMDAR-NR1. The number of co-localized 
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synapses was quantified using an orthogonal Z-stack (Z-step .89um, 16 Z-steps) on 
basilar dendrites for a 40um length starting at the cell soma. Our results showed that 
after 3 weeks, no differences were found between groups in the number of excitatory 
synapses on layer V pyramidal neurons. However, after 8 weeks, the number of 
excitatory synapses in the aged OVX female group was significantly less than that of 
the intact females and age-matched males. These results indicate a possible long-term 
effect of estradiol and related sex hormone depletion on neocortical synaptic number in 
aged females.  
INTRODUCTION 
 Synaptic proteins are an integral part of the synaptic unit and are subject to 
many factors, including sex hormones, synaptic signal strength, neuronal health and the 
extra-synaptic environment (Foy et al., 2008). This synaptic integration is crucial for 
communication in the nervous system and allows for modification and inhibition of cell 
signaling (Phan et al., 2012; Brocca et al., 2013). Damage to the communication 
pathways in the brain has been shown to impair those signals and subsequently 
interrupt normal behavior or other physiologic transmission (Phan et al., 2012; Brocca 
et al., 2013). In this case, ischemic damage to the motor cortex results in a decrease in 
healthy brain tissue (resulting in an infarct, or damaged and dead tissue). Repair and 
subsequent functional recovery depends on these areas re-establishing proper 
communication to motor areas in order for functional motor behavior to ensue. Synaptic 
proteins are integral to forming these required synapses and are dependent on 
neuronal connectivity (Norbury et al., 2003; Minamo et al., 2008; Phan et al., 2012; 
Baudry et al., 2013; Brocca et al., 2013). 
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 Potential sex differences in synaptic number in the motor cortex could be used 
to explain the behavioral differences seen in learning and post-stroke recovery. 
Estradiol has been shown to increase synaptic number (Wu et al., 2005; Foy et al., 
2008; Kramer et al., 2013), but it is uncertain whether stroke reduces the number of 
synapse numbers in rats, especially at different time points of recovery. The motor 
cortex’s connections to the thalamus and other parts of the cortex are used in relaying 
movement information (Kaneko, 2013). Proper cortical connectivity is essential in 
learning and recovery as this communication is necessary for the motor movement 
pathways (Brocca et al., 2013). Disruption of these pathways will negatively impact 
behavior, while eventual restoration of connectivity could allow for functional motor 
recovery. The focus of this study is the excitatory connections to the pyramidal layer V 
forelimb motor cortex via the pre-synaptic markers VGLUT1 (cortico-cortical 
connections) and VGLUT2 (thalamo-cortical connections), which are the glutamate 
transporters that fill the vesicles with glutamate (Kaneko, 2013).  
METHODS 
All experimenters were blinded to rat group and treatment. 
Animal Subjects 
All animal experiments and protocols were approved by the Institutional Animal Care 
and Use Committee of the Hines Veterans Affairs Hospital in Hines, IL. A total of 36 
aged male and female Fischer 344 albino rats (18 months of age at start of the study) 
were divided into three groups: normal males, normal (intact) females, and 
ovariectomized (OVX) females. Rats were housed two to a cage and were maintained 
in a 12 hour light/dark cycle with free access to water (Figure 15).  
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RAT GROUPS AND NUMBERS 
 
Power Analysis:  
For this aim, we started with a power analysis and incorporated six experimental groups 
for comparison, setting alpha at 0.05.  A sample size of 36 with 6 animals per group 
(IHC 3 and 8 week time-points) will be needed to achieve power of 0.8.   
 
 
 
 
 
 
 
 
 
 
 
 
 Stroke No Stroke  
Male 6 6  
Female 6 6  
OVX Female 6 6  
Total 18 18 36 
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Figure 15. Experimental Timeline of Aim 1. Rats received a stroke to the right 
hemisphere and immediately after received an AAV injection to the contralesional 
cortex. Three weeks post-stroke, half of the rats were sacrificed for IHC and lesion 
analysis. The other half were sacrificed at 8 weeks post-stroke. 
 
Ovariectomy (OVX) 
Twelve females received an OVX in which both ovaries were removed. Rats were 
anesthetized using 2% isoflurane with oxygen and had both flanks shaved between rib 
cage and pelvic bones. A one centimeter incision was made in the skin followed by a 
one centimeter incision in the underlying muscle wall. Ovaries were found by pulling 
underlying fat tissue and isolating the ovary. Oviducts were tied off and cut right below 
the ovary body. The muscles and skin were then sutured.  
Estradiol Serum Measurements Via Enzyme-linked Immunosorbent Assay (ELISA) 
One week after ovariectomy all female rats had tail vein blood collected for ELISA 
estradiol serum level determination. Tail blood was spun down and the serum was 
collected and then processed using Cayman Chemical’s Estradiol EIA Kit (Item 582251 
Ann Arbor, MI). The kit’s detectable level for estradiol was 19pg/mL. 
 
 
 
 
No Stroke/AAV 
Injection or 
Stroke/AAV 
Injection 
3 weeks: Sacrifice 
for Histology 
1 week 
S 
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Stroke Surgery 
Middle Cerebral Artery Occlusion (MCAO) was performed as described in our previous 
work (Markus et al., 2005; Gillani et al., 2010). Animals were anesthetized (2-3% 
isoflurane in oxygen) and secured in a stereotaxic frame. An incision was made through 
the scalp and underlying muscle and the skull opened with a dental drill. The middle 
cerebral artery was then isolated and ligated by a 10-0 silk suture and transected with 
microscissors. Core body temperature was maintained at 37 degrees Celsius. The 
scalp was sutured closed and rats returned to their home cages. 
Adeno-Associated Virus (AAV) Injection 
AAV2/8-CMV-GFP-LDL-RCT (Adeno-associated Virus Serotype 2/8 – Cytomegalovirus 
plasmid – Green Fluorescent Protein – Directed to Plasma Membrane) was injected in 
the contralesional forelimb motor cortex to label layer V pyramidal neurons (2 injection 
sites (Coordinates: 3 mm lateral, bregma, 1.5 mm ventral; 2.5 mm lateral, 0.5 mm 
anterior, 1.5 mm ventral), 1 uL each injection site; 1.3x10E12 vector genomes/ml titer). 
This paradigm has been used in our previous publications (Pradhan et al, 2010) and 
results in excellent labeling of dendrites and spines as the myristoylated GFP targets 
the neuronal cell membrane (Kameda et al, 2008) (Figures 16 and 17). 
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Figure 16. Infarct Location. Shown here is the typical infarct size and location of the 
rat motor cortex and the contralesional AAV injection that follows. No-stroke rats also 
received AAV injection in the left hemisphere. 
Perfusion 
Three and eight weeks after stroke, rats were sacrificed and perfused with 0.9% saline 
followed by 4% paraformaldehyde. Brains were allowed to sit overnight in 4% 
paraformaldehyde before being placed in 30% sucrose until sinking. They were then 
frozen in tissue medium (OCT) and stored at -80 degrees Celsius. 
Immunohistochemistry and Analysis 
Brains were cut at 50 um on a -20 degree Celsius cryostat before lipofuscin removal 
and antigen retrieval. Primary antibodies against NMDA Receptors (NR1 subunit) 
(mouse IgG2, Life Technologies 32-0500), vesicular glutamate transporter 1 and 2 
(VGLUT1 and 2) (guinea pig IgG1, EMD AB5905) and anti-GFP (rabbit, Life 
Technologies A11122) were used. Sections from the same anatomical location from 
each brain were used for IHC (three from each brain) – 2nd, 8th, 14th sections starting 
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collecting at the beginning of when the hemispheres connect via the corpus callosum 
(Bregma +1.66mm) (Figure 17). 
Free-floating sections were incubated for 30 minutes at room temperature in 50uM 
cupric sulfate in 100uM ammonium acetate for lipofuscin removal. Sections were then 
washed and incubated for 30 minutes at 80 degrees Celsius in pH 6 citrate buffer for 
antigen retrieval. Sections were washed and incubated at 4 degrees Celsius for 24 
hours in one of the following parameters:  
• Anti-VGlut1 (1:1000), Anti-GFP (1:1000), Anti-NMDAR (1:1000) 
• Anti-VGlut2 (1:1000), Anti-GFP (1:1000), Anti-NMDAR (1:1000) 
• Anti-Nogo-A (1:10,000), Anti-VGlut1 (1:1000), Anti-GFP (1:1000). 
Sections were then washed and incubated in secondary antibody (goat anti-rabbit, IgG 
Life Technologies A-11070; goat anti-guinea pig, IgG VWR RL606-143-129; goat anti-
mouse IgG Life Technologies A-11019) (1:500) for two hours at room temperature plus 
DAPI stain before washing and mounting on slides. Brain sections were mounted on 
slides and examined with a confocal microscope (Leica High Resolution Confocal TCS-
SPE) and deconvolution software. GFP-labeled pyramidal neurons from the 
sensorimotor forelimb cortex were identified by morphology. For each rat, z-stacks of 
dendritic segments from 5 different neurons were imaged in the basilar arbors, and 
analyzed for density of the specific synaptic protein-positive puncta co-localized with 
EGFP with ImageJ software (NIH) (Z-step .89um, 16 Z-steps). After full z-stack photo 
was taken, the image was flipped orthogonally (Figure 18) and the chosen dendrite was 
measured 40um from the soma so as to confirm co-localization (Figure 19 and 20). The 
co-localized puncta were counted and categorized according to placement on the 
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dendritic shaft or spine within that 40um distance. Non-specific labeling was checked by 
incubating one section per rat in a secondary antibody only, primary antibody only, and 
cross-reactivity was checked by one section in each non-correct primary-secondary 
antibody pairing (i.e., mouse primary antibody with anti-rabbit secondary antibody. No 
non-specific binding or cross-reactivity was observed. Quantification was done by 
confirming yellow co-localization within the 40 um distance from soma. 
 
 
Figure 17. Cortical Connections and AAV Injection Location. Shown here are the 
pyramidal layer V neural connectivity with excitatory connections from the cortex (layers 
2/3, 5 and 6 from both hemispheres) and from the VA/VL nuclei of the thalamus. Brain 
section diagram from Paxinos and Watson, 1998. 
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Figure 18. Orthogonal View of Z Stack. Panel A shows the Z-stack image after 
capturing on the confocal microscope, with panel B showing the same image flipped 
orthogonally to be certain of co-localization of pre- and post-synaptic fluorescence on 
the dendrite. 
 
A 
B 
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Figure 19. Quantification of Synapses. Quantification of green-labeled pre-synaptic 
markers (vGlut1 or vGlut2), red post-synaptic markers (NMDAR-NR1 subunit) and the 
GFP-labeled neuronal soma and dendrites. Quantification must be within the 40um 
distance from the soma, the post-synaptic marker must be making contact with the 
dendrite and there must be some overlap between the post- and pre-synaptic markers 
(yellow). Circles indicate a countable triple-labeling. 
 
Soma 
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Figure 20. Example of Synapse Quantification. Sample photomicrographs obtained 
from an intact female rat shows (A) a GFP-labeled basilar dendrite, (B) the post-
synaptic marker (NMDAR-NR1) in red, (C) the pre-synaptic marker (VGLUT2) in green 
(D) and the merge of all three images. Arrows indicate sample co-localizations (yellow). 
Scale bar = 5um. 
 
  
A. GFP B. NMDAR-NR1 
C. VGLUT2 D. Merge 
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Lesion Analysis 
The lesion volume was analyzed using alternate Nissl stained sections. The area of the 
intact contralateral hemisphere was measured then subtracted from the area of the 
intact ipsilateral hemisphere. This was then multiplied by the distance between 
sections. Area of stroke was expressed as a percentage of the intact contralateral 
hemispheric volume. 
Statistical Analysis 
P values of less than 0.05 were considered significant. 
All data analysis was performed with GraphPad Prism Version 6.0 software (La Jolla, 
CA USA) for repeated-measures ANOVA and one-way ANOVA with Tukey post-hoc 
tests or SPSS (IBM, Armonk, NY, USA) for F statistics. 
F statistics were determined for this aim. A one-way ANOVA with Tukey’s post hoc 
analysis was used to compare the mean of the IHC data and lesion analysis data after 
measuring F statistic. Correlative statistics were done for each rat on lesion size and 
synaptic number using the correlation coefficient (r). A p value less than or equal to 
0.05 was be considered significant and a correlation coefficient of less than 0.5 was 
considered weakly correlating. 
RESULTS 
Estradiol Blood Serum Levels 
The estradiol serum levels in the females were as follows: the average estradiol level in 
the intact females (n=9) was 53.7 pg/mL (± 10.36pg/mL) whereas the ovariectomized 
females (n=8) were all below the detectable limit of 19 pg/mL. 
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Lesion Analysis 
Lesion analysis of the stroke brains revealed no significant difference in lesion size 
between groups (Figure 21). 
  
Figure 21. Lesion analysis in the aged rat after stroke. Lesion analysis showed no 
difference in stroke size between aged male, aged female, and aged 
female/ovariectomized (OVX) rats. (p>0.05). Error bars represent standard error of the 
mean. 
 
VGLUT1 and VGLUT2 Co-Localization 
When quantifying VGLUT1 synapses on Layer V pyramidal neurons with no cortical 
lesion (ie, no stroke), we found that all three groups had the same number of synapses 
with no differences between groups at the three week time point. Furthermore, at three 
weeks post-stroke/AAV injection there were still no differences between groups (Figure 
22). Although there was a trend for decreased VGLUT1 synapses following stroke, this 
was not significantly different. 
0
2
4
6
8
10
12
14
16
1
Female Stroke
Male Stroke
OVX Stroke
 
Le
si
o
n
 P
e
rc
en
ta
ge
 o
f 
H
em
is
p
h
er
e
 
  55 
 
The F test conducted revealed significant group effects [F(6, 35) = 28.78, p < 0.05]. 
When quantifying VGLUT1 synapses at eight weeks post-AAV injection, we found 
significant differences. AAV-only females had the highest counted co-localizations in 
this instance and post-hoc revealed were significant when compared to AAV-only OVX 
females (p < 0.05) and stroke intact females (p < 0.05). AAV-only males were 
significant when compared to stroke males (p < 0.05) (Figure 22). There was no 
difference between OVX groups with and without stroke. 
When quantifying VGLUT2 synapses on Layer V pyramidal neurons with no cortical 
lesion (ie, no stroke), we found that all three groups had the same number of synapses 
with no differences between groups at the three week time point. Furthermore, at three 
weeks post-stroke/AAV injection there were still no differences between groups (Figure 
23), although there was a trend for decreased VGLUT2 synapses following stroke, this 
was not significantly different. 
The F test conducted revealed significant group effects [F(6, 35) = 31.11, p < 0.05]. 
When quantifying VGLUT2 synapses at eight weeks post-AAV injection, we found 
significant differences. There was no decrease in synaptic number following stroke in 
either the intact female or OVX female groups. Post-hoc revealed AAV-only males were 
significant when compared to stroke males (p < 0.05) (Figure 23). Post-stroke, intact 
females had significantly higher synaptic counts than both stroke males (p < 0.05) and 
stroke OVX females (p < 0.05) (Figure 23). There was no difference between OVX 
groups with and without stroke. A representative image is used to illustrate the punctae 
in Figure 28. 
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There was no observed correlations between lesion size and synapse number for any 
groups and either time point (Figures 23 through 27). 
 
 
 
 
Figure 22. VGLUT1 Synapses. Above is VGLUT1 punctae co-localization with 
NMDAR and GFP-labeled dendrite quantification from both three weeks post-injection 
and eight weeks. * indicates p < 0.05. Error bars represent standard error of the mean. 
NS = Not significant. 
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Figure 23. VGLUT2 Synapses. Above is VGLUT2 punctae co-localization with 
NMDAR and GFP-labeled dendrite quantification from both three weeks post-injection 
and eight weeks. * indicates p < 0.05. Error bars represent standard error of the mean. 
NS = Not Significant. 
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Figure 24. VGLUT1 3 week Correlation. VGLUT1 correlation showing weak 
correlation between lesion size and VGLUT1 punctae (green = intact female stroke, 
blue = male stroke, red = OVX stroke). 
 
 
Figure 25. VGLUT2 week 3 Correlation. VGLUT2 correlation showing weak 
correlation between lesion size and VGLUT2 punctae (green = intact female stroke, 
blue = male stroke, red = OVX stroke). 
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Figure 26. VGLUT1 8 week Correlation. VGLUT1 correlation showing weak 
correlation between lesion size and VGLUT1 punctae (green = intact female stroke, 
blue = male stroke, red = OVX stroke). 
 
 
Figure 27. VGLUT2 8 week Correlation. VGLUT2 correlation showing weak 
correlation between lesion size and VGLUT2 punctae (green = intact female stroke, 
blue = male stroke, red = OVX stroke). 
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Figure 28. Intact Female Sample Image. Sample photomicrographs obtained from an 
intact female rat shows a very high density of NMDAR co-localizing (yellow) with a pre-
synaptic marker on cyan dendrites (Blue = DAPI) in an intact female. Scale bar = 5um. 
Arrows denote three examples of yellow co-localization. 
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DISCUSSION 
The results from this study showed that the number of excitatory synapses on layer V 
pyramidal neurons in the forelimb motor cortex are similar between aged males and 
female rats. However, this number is influenced by factors such as estradiol and related 
sex hormone levels and cortical injury. Specifically, when examining VGLUT1 
synapses, which are indicative of cortico-cortical connections, there was a decrease in 
number by nine weeks post-OVX. VGLUT2 synapse number, which primarily arises 
from thalamo-cortical connections, did not show this decrease, supporting the idea that 
estradiol and related sex hormones may be more important for maintaining cortico-
cortical connectivity. 
When examining synapse number in the contralesional cortex post-stroke, both aged 
males and females showed a decrease in VGLUT1 synapse number by eight weeks 
post-stroke. This is consistent with others who have reported a decrease in dendritic 
complexity (Papadopoulos et al., 2002; Papadopoulos et al., 2006; Gillani et al., 2010). 
This decrease in expected due to the effects of the stroke lesion which would 
essentially eliminate and de-enervate any cortico-cortical connections to the homotopic 
forelimb motor cortex. In our study we did not observe a further decrease in VGLUT1 
synapse number in the OVX group, suggesting that the effect of the stroke was not 
‘strong’ enough to deplete this already low synapse number further than it had already 
dropped. This shows a potential time effect post-stroke of a loss of excitatory synapses 
in the pyramidal layer V motor cortex. 
When examining VGLUT2 synapse number post-stroke, we found that only the aged 
male group showed a significant decrease in this synapse number. In fact, aged 
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females had significantly more VGLUT2 synapses than aged males or OVX females. 
Therefore, VGLUT2 synapses, which are a reflection of thalamo-cortical connectivity, 
were differentially affected by the cortical ischemic infarction, with aged males being 
more susceptible to this injury. This also shows a potential time effect post-stroke of a 
loss of excitatory synapses in the pyramidal layer V motor cortex. 
These results also show that there was no correlation between lesion size and synapse 
counts for any protein or time point examined (Figures 24 through 27). This is possibly 
due to the consistent focal stroke size across all groups and both time points. Stroke 
size has been shown by others to be reduced by estradiol presence (Dang et al., 2011) 
but those levels used in that report were high (and exogenous) and not the low basal 
levels seen in our intact females (or possibly in our males through aromatization of 
testosterone). With a larger n there may be a stronger correlation. 
Estradiol has been shown to play a role in upregulating dendrites, spines, and synapse 
proteins (Norbury et al., 2003; Minamo et al., 2008; Baudry et al., 2013). Estradiol has 
been shown to be neuroprotective in some studies (Dang et al., 2011; Kao et al., 2013) 
but the mechanism is still under investigation. It is proposed that adipose tissue could 
release stored sex hormone during stroke, which may have been seen at three weeks 
but not eight. It has been proposed to activate Akt (Spencer et al., 2008; Kao et al., 
2013) and also proposed to upregulate cyclic-AMP response element binding protein 
(CREB) which can increase transcription of anti-apoptotic genes such as Bcl-2 (Lokuge 
et al., 2010) as well as activating both Akt and Bcl-2 (Li et al., 2013). Others have 
argued that estradiol’s neuroprotection depends on the age of the organism (Leon et 
al., 2011) with an older animal not responding as well to estradiol administration as 
stroke treatment. Not yet investigated widely is the effect of testosterone on synapses, 
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but it is possible to aromatize it to estradiol via aromatase and have a similar effect as 
long as the receptors are present (Dubal and Wise, 2001; Etgen et al., 2011; Chen et 
al., 2013). 
Some have speculated that estrogen and progesterone may act through other 
mediators, such as secondary response systems to enhance recovery following stroke. 
Stem cells are proposed to be activated by estradiol (Li et al., 2011; McClure et al., 
2013) and estradiol has been proposed to even have effects in the peripheral nervous 
system (Nowacek and Sengelaub, 2006). Furthermore, progesterone has been shown 
to have neuroprotective and pro-growth abilities (Stein, 2001; Toung et al., 2004). 
The neuronal synapse has much astrocytic involvement, especially in terms of 
neurotransmitter reuptake (Chisholm and Sohrabji, 2015) and plays a large part in 
aging, stroke, and potentially post-stroke repair (Chisholm and Sohrabji, 2015), with 
others proposing a sex difference as well (namely females have more astrocytic 
involvement on synapses) (Brandt et al., 2013). 
In conclusion, the results from this study show that the number of excitatory synapses is 
affected by sex hormones and cortical lesion, and are dependent on the time point 
examined following stroke. Synaptic numbers are signifiers of axonal pathways and are 
important in measuring recovery. The infarct from a stroke (or similar lesion, such as 
from a traumatic brain injury) results in a death of neurons and decrease in synaptic 
connections. The contralesional hemisphere is believed to play a significant role in 
taking over some of the function lost by the damaged hemisphere. The differences 
observed in this aim show that synaptic differences do exist between groups and that 
time changes the numbers of these synapses. Inhibitory synapses is another area to 
  64 
 
study as only excitatory synapses were studied here, and present another realm of 
altered synapses following injury, along with the fact that only the pyramidal cells of the 
layer V motor cortex were examined. Other areas may yield different results, such as 
another cortical layer or another brain region (thalamus or red nucleus for example). 
Different cell types may also yield other results, such as the inhibitory cells of the cortex 
or the non-pyramidal cells of layer V. The dendrites studied were also only basilar 
dendrites, and apical dendrites are another area of study.  
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CHAPTER FOUR 
EFFECTS OF ANTI-NOGO-A IMMUNOTHERAPY ON SYNAPTIC NUMBER IN THE 
RAT FORELIMB MOTOR CORTEX AFTER STROKE 
ABSTRACT 
We have shown previously that anti-Nogo-A immunotherapy post-stroke increased 
functional recovery and axonal and dendritic complexity in the male rat (Papadopoulos 
et al., 2002; Papadopoulos et al., 2006; Markus et al., 2005; Seymour et al., 2005). 
Dendritic plasticity following stroke has been previously measured (Papadopoulos et al., 
2002; Papadopoulos et al., 2006; Gillani et al., 2010), but which synapses these 
dendrites are making has not yet been investigated. Male, intact female, and OVX 
females received a stroke to the right hemisphere (because no behavioral analysis to 
determine limb preference was done) one week following OVX. Immediately following 
stroke a miniosmotic pump was inserted into the contralesional lateral ventricle with 
either 11C7 or control antibody (anti-BrdU) and AAV pre-labeling was injected into the 
contralesional forelimb motor cortex. Two weeks later pumps were removed. Rats were 
sacrificed 3 weeks after stroke for IHC. Results showed that anti-Nogo-A immunotherapy 
significantly increased excitatory synapse number for both VGLUT1 and VGLUT2 in 
male and intact female groups. OVX females did not have a significant increase 
following immunotherapy. Our results show that anti-Nogo-A immunotherapy is effective 
in increasing excitatory synapse number in the aged rat, but lack of estradiol or other sex 
hormones could impact its usefulness. 
65 
 
66 
 
 
INTRODUCTION 
The disabilities left by a stroke can be very damaging, with rehabilitation being the 
mainstay of alleviating those disabilities. Patients are often left with permanent deficits 
(Alaverdashvili and Whishaw, 2010; Wahl and Schwab; 2014; Wahl et al., 2014). The 
novel therapeutic Anti-Nogo-A immunotherapy has been shown in the past to reduce 
post-stroke motor deficits and increase functional recovery (Papadapoulos et al., 2002; 
Markus et al., 2005; Tsai et al., 2007). Most research into stroke recovery, and 
specifically Anti-Nogo-A immunotherapy, has focused on young, male rats. This makes 
an aged female investigation particularly noteworthy and necessary due to the apparent 
sex differences observed in the human population. This is true not only in stroke 
recovery, but also in neuronal connectivity (Bushnell, 2005) and the how synapses can 
contribute to motor recovery.  
Of interest is the mechanism of how anti-Nogo-A immunotherapy increases functional 
recovery. While it has been known that both the Nogo receptors and estradiol act 
through the RhoA pathway (Kramar et al., 2013; Schwab and Strittmatter, 2014), it is 
unclear if there is any interaction between the two and the resulting synaptic changes 
that occur. Earlier work has shown that intrathecal infusion of the anti-Nogo-A antibody 
over two and four weeks increased the amount of VGLUT1 in the hippocampus in young 
male rats (Craveiro et al., 2013). 
Much research into anti-Nogo-A immunotherapy has focused on behavioral and 
morphological changes (Papadapoulos et al., 2002; Papadapoulos et al., 2006; Gillani et 
al., 2010). The previous work in our lab has correlated improved functional outcome with 
both dendritic plasticity (Papadopoulos et al., 2006) and axonal plasticity (Padapolous et 
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al., 2002; Seymour et al., 2007; Tsai et al., 2007; Tsai et al., 2011) emanating from the 
contralesional motor cortex after treatment with anti-Nogo-A immunotherapy post-stroke. 
Specifically in these studies the dendritic and axonal plasticity targeted large pyramidal 
neurons in layer V of the contralesional cortex. There neurons constitute the main 
efferent output to important descending motor pathways controlling motor movements. 
The novelty of this study then is the usage of confocal microscopy to determine ‘triple 
labeling’ of a pre-synaptic marker (VGLUT), a post-synaptic marker (NMDAR), with the 
NMDAR on the GFP expressed by pre-label layer V pyramidal dendrites. How much 
anti-Nogo-A changes these excitatory cortical connections can also reveal sex 
differences and if the behavioral effects of anti-Nogo-A could be mechanistically 
explained by excitatory synaptic changes. 
Therefore, the purpose of this study was to investigate the effect of anti-Nogo-A 
immunotherapy on excitatory synaptic proteins in the contralesional motor cortex post-
stroke. 
METHODS 
All experimenters were blinded to rat group and treatment. 
Animal Subjects 
All animal experiments and protocols were approved by the Institutional Animal Care 
and Use Committee of the Hines Veterans Affairs Hospital in Hines, IL. A total of 29 
aged male and female Fischer 344 albino rats (18 months of age at start of the study) 
were divided into three groups: normal males, normal (intact) females, and 
ovariectomized (OVX) females (Figure 29). Rats were housed two to a cage and were 
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maintained in a 12 hour light/dark cycle with free access to water. Rats were given food 
and water ad libitum.  
ANIMAL GROUPS AND NUMBERS 
 
Power analysis:  
For this aim, we started with a power analysis and incorporated six experimental groups 
for comparison, setting alpha at 0.05.  A sample size of 29 and 4-5 animals per group 
will be needed to achieve power of 0.8.   
EXPERIMENTAL TIMELINE
 
Figure 29: Experimental Timeline of Aim 2. Rats will receive a stroke to the right 
hemisphere and immediately after receive an AAV injection to the contralesional cortex 
followed by antibody pump placement into the contralesional lateral cerebral ventricle. 
Two weeks post-stroke pumps will be removed. Three weeks post-stroke, the rats will be 
sacrificed for IHC and lesion analysis. 
 Stroke + 11C7 
(IHC) 
Stroke + control Ab 
(IHC) 
 
Male 4 5  
Female 5 5  
OVX Female 5 5  
Total 14 15 29 
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Ovariectomy (OVX) 
Ten females received an OVX in which both ovaries were removed. Rats were 
anesthetized using 2% isoflurane with oxygen and had both flanks shaved between rib 
cage and pelvic bones. A one centimeter incision was made in the skin followed by a 
one centimeter incision in the underlying muscle wall. Ovaries were found by pulling 
underlying fat tissue and isolating the ovary. Oviducts were tied off and cut right below 
the ovary body. The muscles and skin were then sutured. 
Estradiol Serum Measurements Via Enzyme-linked Immunosorbent Assay (ELISA) 
One week after ovariectomy all female rats had tail vein blood collected for ELISA 
estradiol serum level determination. Tail blood was spun down and the serum was 
collected then processed using Cayman Chemical’s Estradiol EIA Kit (Item 582251 Ann 
Arbor, MI). The kit’s detectable level for estradiol was 19pg/mL. 
Stroke Surgery 
MCAO was performed as described in our previous work (Markus et al., 2005; Gillani et 
al., 2010). Animals were anesthetized (2-3% isoflurane in oxygen) and secured in a 
stereotaxic frame. An incision was made through the scalp and underlying muscle and 
the skull was opened with a dental drill. The middle cerebral artery was then isolated and 
ligated by a 10-0 silk suture and transected with microscissors. Core body temperature 
was maintained at 37 degrees Celsius. The scalp was sutured closed and rats returned 
to their home cages. 
Adeno-Associated Virus (AAV) Injection 
AAV2/8-CMV-GFP-LDL-RCT was injected in the contralesional forelimb motor cortex to 
label layer 5 pyramidal neurons (2 injection sites (Coordinates: 3 mm lateral, bregma, 
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1.5 mm ventral; 2.5 mm lateral, 0.5 mm anterior, 1.5 mm ventral), 1 uL each injection 
site; 1.3x10E12 vector genomes/ml titer). This paradigm has been used in our previous 
publications (Pradhan et al, 2010) and results in excellent labeling of dendrites and 
spines as the myristoylated GFP targets the neuronal cell membrane (Kameda et al, 
2008) (Figure 30).  
Antibody Infusion Via Osmotic Mini-pumps 
Immediately following stroke and AAV injection, mini-osmotic pumps were placed for ICV 
delivery of either purified mouse monoclonal anti-Nogo-A antibody (11C7, IgG1; 2.5 
mg/mL concentration) or control antibody (anti-bromodeoxyuridine (BrdU), IgG1; 2.5 
mg/mL concentration) infused at a rate of 12.5 micrograms/hour for two weeks as 
described in our previous publications in the contralesional lateral ventricle 
(Papadapoulos et al., 2002; Gillani et al., 2010). At the end of two weeks, pumps were 
removed and rats were re-sutured. Pumps were confirmed to work by measuring amount 
of antibody solution left over after pumps were removed. Any pump with over half the 
amount of the starting volume (2 milliliters) was determined to be not working and the rat 
was removed from the study. 
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Figure 30. Injection and Pump Insertion sites. Shown here is the typical infarct size 
and location in the rat motor cortex, the AAV inject site, and the location of the mini-
osmotic pump as it is inserted into the lateral ventricle. 
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Perfusion 
Three weeks after stroke, rats were sacrificed and perfused with 0.9% saline followed by 
4% paraformaldehyde. Brains were allowed to sit overnight in 4% paraformaldehyde 
before being placed in 30% sucrose until sinking. They were then frozen in tissue 
medium (OCT) and stored at -80 degrees Celsius.  
Immunohistochemistry and Analysis 
Brains were cut at 50 um on a -20 degree Celsius cryostat before lipofuscin removal and 
antigen retrieval. Primary antibodies against NMDA Receptors (NR1 subunit) (mouse 
IgG2, Life Technologies 32-0500), vesicular glutamate transporter 1 and 2 (VGLUT1 and 
2) (guinea pig IgG1, EMD AB5905) and anti-GFP (rabbit, Life Technologies A11122) 
were used. The same sections from each brain were used for IHC (three from each 
brain) – 2nd, 8th, 14th sections starting collecting at the beginning of when the 
hemispheres connect (Bregma +1.66mm).  
Sections were incubated for 30 minutes at room temperature in 50uM cupric sulfate in 
100uM ammonium acetate for lipofuscin removal. Sections were then washed and 
incubated for 30 minutes at 80 degrees Celsius in pH 6 citrate buffer for antigen 
retrieval. Sections were washed and incubated at 4 degrees Celsius for 24 hours in one 
of the following parameters:  
• Anti-VGlut1 (1:1000), Anti-GFP (1:1000), Anti-NMDAR (1:1000) 
• Anti-VGlut2 (1:1000), Anti-GFP (1:1000), Anti-NMDAR (1:1000) 
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Sections were then washed and incubated in secondary antibody (goat anti-rabbit, IgG 
Life Technologies A-11070; goat anti-guinea pig, IgG VWR RL606-143-129; goat anti-
mouse IgG Life Technologies A-11019) (1:500) for two hours at room temperature plus 
DAPI stain before washing and mounting on slides. Brain sections were mounted on 
slides and examined with a confocal microscope (Leica High Resolution Confocal TCS-
SPE) and deconvolution software. EGFP-labeled pyramidal neurons from the 
sensorimotor forelimb cortex were identified by morphology. For each rat, z-stacks of 
dendritic segments from 5 different neurons were imaged in the basilar arbors, and 
analyzed for density of the specific synaptic protein-positive puncta co-localized with 
EGFP with ImageJ software (NIH) (Z-step .89um, 16 Z-steps). After full z-stack photo 
was taken, the image was flipped orthogonally (Figure 17) and the chosen dendrite was 
measured 40um from the soma so as to confirm co-localization (Figure 18 and 19). The 
co-localized puncta were counted and categorized according to placement on the 
dendritic shaft or spine within that 40um distance. Non-specific labeling was checked by 
incubating one section per rat in a secondary antibody only, primary antibody only, and 
cross-reactivity was checked by one section in each non-correct primary-secondary 
antibody pairing (ie, mouse primary antibody with anti-rabbit secondary antibody. No 
non-specific binding or cross-reactivity was observed. 
Lesion Analysis 
The lesion volume was analyzed on alternate Nissl stained sections. The area of the 
intact contralateral hemisphere minus the area of the intact ipsilateral hemisphere was 
multiplied by the distance between sections. Area of stroke was expressed as a 
percentage of the intact contralateral hemispheric volume. 
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Statistical Analysis 
All data analysis was performed with GraphPad Prism Version 6.0 software (La Jolla, CA 
USA) for repeated-measures ANOVA and one-way ANOVA with Tukey post-hoc tests or 
SPSS (IBM, Armonk, NY, USA) for F statistics. A one-way ANOVA with Tukey’s post 
hoc analysis was used to compare the mean of the IHC data and lesion analysis data 
after measuring F statistic. Aim 1 rat values for the stroke-only groups were used for 
synaptic number comparison. Correlative statistics was done for each rat on lesion size 
and synaptic plasticity using the correlation coefficient (r). A p value less than or equal to 
0.05 will be considered significant and a correlation coefficient (r squared) of less than 
.50 will be considered weakly correlating. 
RESULTS 
Lesion analysis revealed that there were no group differences in lesion size, nor was 
there a lesion size difference due to antibody treatment (Figures 31 and 32). Previously, 
our lab has shown that anti-Nogo-A immunotherapy does not alter lesion size (Seymour 
et al., 2005; Tsai et al., 2007; Gillani et al., 2011). 
The F test conducted revealed significant group differences [F(3, 28) = 19.74, p < 0.05]. 
For VGLUT1 post-hoc, there was a significant increase seen in the number of synapses 
following anti-Nogo-A immunotherapy for intact females and males (Figure 37) (p < 
0.05). There was no significant increase for OVX females (p = .68). The control antibody 
did not significantly increase synaptic counts for any group. 
The ANOVA conducted revealed significant group effects [F(3, 28) = 22.65, p < 0.05]. 
For VGLUT2 post-hoc, there was a significant increase seen in the number of synapses 
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following anti-Nogo-A immunotherapy for intact females and males (Figure 38) (p < 
0.05). There was no significant increase for OVX females (p = .70). The control antibody 
did not significantly increase synaptic counts for any group. Representative images are 
shown in figure 33. A sample imaged zoomed to show synapses on the dendritic spines 
is shown in figure 34. 
It was also shown that there was no correlation between lesion size and co-localized 
punctae counts (Figures 37 through 40). 
  
Figure 31. Aim 2 Lesion Analysis. There was no observed significant difference 
between groups or antibody treatment. Error bars represent standard error of the mean. 
Figure 32 shows a sample lesion size for the antibody treatment. 
 
 
Figure 32: Representative pictures of typical lesion sizes and locations. 
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Figure 33. MCAO Intact Female Control Antibody Image. This sample 
photomicrograph is a representative image of a very high density of NMDAR co-
localizing (yellow) with a pre-synaptic marker on cyan dendrites (Blue = DAPI) in a 
control antibody MCAO intact female. Scale bar 5um. Arrows denote three examples of 
yellow co-localization. 
. 
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D.  
 
Figure 34. Dendritic Spines. With 400X magnification, some dendritic spines (arrows) 
can be seen in grey (A), along with NMDAR marking the post-synapse (red) (B), and 
VGLUT2 marking the pre-synapse (green) (C, merge). Figure D shows the green and 
red punctae on a dendritic spine connected to a soma (also 400X magnification) using 
VGLUT1. Scale bar 1um. 
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Figure 35. VGLUT1 Synapses After Immunotherapy. Above is a bar graph of 
VGLUT1 punctae co-localization with NMDAR and GFP-labeled dendrite quantification 
from three weeks post-injection in control antibody and 11C7-infused rats. Included from 
Aim 1 are the stroke-only group values.  * indicates p < 0.05. Error bars represent 
standard error of the mean.  
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Figure 36. VGLUT2 Synapses after Immunotherapy. Above is a bar graph of VGLUT2 
punctae co-localization with NMDAR and GFP-labeled dendrite quantification from three 
weeks post-injection in control antibody and 11C7-infused rats. Included from Aim 1 are 
the stroke-only group values. * indicates p < 0.05. Error bars represent standard error of 
the mean. 
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Figure 37. VGLUT1 with Control Antibody Correlations. VGLUT1 correlation showing 
weak correlation between lesion size and VGLUT1 punctae (blue = stroke males, green 
= stroke intact females, red = stroke OVX females) in control antibody-treated rats. 
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Figure 38. VGLUT2 with Control Antibody Correlations. VGLUT2 correlation showing 
weak correlation between lesion size and VGLUT2 punctae (blue = stroke males, green 
= stroke intact females, red = stroke OVX females) in control antibody-treated rats. 
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Figure 39. VGLUT1 with 11C7 Antibody Correlations. VGLUT1 correlation showing 
weak correlation between lesion size and VGLUT1 punctae (blue = MCAO males, green 
= MCAO intact females, red = MCAO OVX females) in 11C7-treated rats. 
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Figure 40. VGLUT2 with 11C7 Antibody Correlations. VGLUT2 correlation showing 
weak correlation between lesion size and VGLUT2 punctae (blue = MCAO males, green 
= MCAO intact females, red = MCAO OVX females) in 11C7-treated rats. 
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DISCUSSION 
The results from this study show that synaptic increases were seen following 11C7 
immunotherapy in male and intact female groups in both synaptic proteins examined 
(Figure 31). Males and intact females had a significant increase in VGLUT1 (Figure 35) 
and VGLUT2 (Figure 36) synapses on contralesional layer V neurons following stroke 
and anti-Nogo-A immunotherapy. OVX females were not shown to increase synapse 
number following immunotherapy for either protein. 
The synaptic proteins we examined reflects part of the sensorimotor functional 
connectivity. VGLUT1 has been shown to be specific for cortico-cortical connections 
while VGLUT2 has been shown to be specific for thalamo-cortical connections (Kaneko, 
2013). Based on previous work, the cortico-cortical connections could be to and from the 
damaged hemisphere, as it has been shown that axon fibers cross the midline to 
innervate the damaged infarct side (Papadapoulos et al., 2002; Papadapoulos et al., 
2006). Using fMRI, our lab has shown that the thalamus is activated following a stroke 
and anti-Nogo-A immunotherapy in aged male rats (Markus et al., 2005), which may 
explain the VGLUT2 (thalamo-cortical) synaptic increase that we report with aged males 
and intact females.  
The lack of increase in the OVX female VGLUT synapses following 11C7 treatment 
could be explained by the lack of estradiol and related sex hormones. Estrogen 
increases dendritic and synaptic number (Schnell et al., 1994; Scharfman and 
MacLusky, 2006; Srivasta et al., 2013). Estradiol signaling has been shown to lead to 
increased levels of CREB (Wu et al., 2005), which as a transcription factor transcribes 
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many pro-growth genes (Wu et al., 2005). Nogo-A signaling has been shown to 
decrease or dephosphorylate CREB, decreasing its activity (Schwab, 2010). 
Progesterone has been shown to reduce neurite growth inhibitors following ischemia 
(Espinosa-Garcia et al., 2014) and the presence of this and estradiol was expected to 
decrease Nogo-A inhibition. We have observed that there was no significant difference 
in VGLUT1 and VGLUT2 co-localization (in either antibody group) due to low estradiol 
(which could result in low progesterone) in the OVX group. Intact females, with a small 
amount of estradiol, did have an increase in synapse number following 11C7 treatment. 
Furthermore, an earlier study reported that 11C7 infusion increased VGLUT1 expression 
in young adult Long-Evans male rats in the hippocampus following intrathecal infusion 
(Craveiro et al., 2013) using Western blot analysis. We have found in terms of our triple 
labeling that this is also shown for the aged males and intact females, but not aged OVX 
females. 
Lesion analysis showed no significant group differences. This can be expected based on 
consistent lesion sizes with this model. This was also seen in our earlier studies using 
anti-Nogo-A immunotherapy (Markus et al., 2005; Seymour et al., 2005; Gillani et al. 
2010). Estradiol and other sex hormones had no noticeable neuroprotective effect, and 
this is believed to be due to the old age of the intact females. It has been shown in 
young adult male and OVX rats that estradiol can reduce infarct size (Dang et al., 2011). 
In terms of correlation between lesion size and synaptic protein punctae, there was no 
correlation found. This was expected because lesion size is not believed to have an 
impact on synaptic protein concentration. If such a correlation exists, it was not detected 
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here. The study of other proteins involved in synaptic connectivity (such as AMPA 
receptors, PSD95, or inhibitory synapse markers) may be of use in the future. 
It has been shown here that following stroke, aged males and intact females responded 
better to 11C7 antibody treatment in terms of increased VGLUT1 and VGLUT2 synapses 
on pyramidal layer V basilar dendrites. The OVX females were shown to have no 
significant difference between control or 11C7 antibody infusion. This could correlate 
with the human clinical data that suggests aged women recover less than men following 
a similar stroke (Bushnell, 2006; Bushnell, 2008; Bushnell et al., 2014). This would be 
due to their low estrogen levels. An underlying mechanism has been postulated that 
estradiol plays a role in actin stabilization through a similar mechanism of Nogo-A via 
RhoA (Wu et al., 2005; Kramer et al., 2013). While estradiol has been shown to have 
many positive effects on dendritic and spine growth and increases NMDAR levels 
(Schnell et al., 1994; Scharfman and MacLusky, 2006; Srivasta et al., 2013) it is 
postulated that estradiol may stabilize actin in this way. In the present study, different 
results were seen in both the intact (with a low level of estradiol) and OVX (no detectable 
serum estradiol) making the level of estradiol present an important factor. The difference 
in estrogen receptor type and concentration between male and female rats may also be 
a resulting difference here. Estradiol, even at a low level in the intact female group, 
would have pro-growth properties for the dendrites and resulting synaptic connections, 
along with inhibiting apoptosis (Wu et al., 2005). Sex hormones were thus shown to play 
a positive role in this study, as evidenced by the lower synaptic counts in the OVX 
female group. 
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In conclusion, it has been shown here that anti-Nogo-A immunotherapy increased the 
number of excitatory synapses in the forelimb motor cortex at three weeks post-stroke 
for aged females and males, however OVX females were shown to have no significant 
increase in synapse number over the control antibody. The low level of estradiol as seen 
in intact aged females may play a role in increasing their responsiveness to anti-Nogo-A 
immunotherapy in terms of excitatory synapse number. 
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CHAPTER FIVE 
SEX DIFFERENCES IN LEARNING SKILLED MOTOR TASKS AND POST-STROKE 
RECOVERY IN THE AGED RAT 
ABSTRACT 
 Sex-based differences in learning and recovery from stroke are an area of 
research not yet fully explored, especially with regard to aged rats performing 
sensorimotor tasks. In the human clinical population, post-menopausal females have 
been shown to recover from stroke less successfully than age-matched males, and 
therefore studying sex differences in rat models of stroke is clinically relevant. Our work 
has shown that aged female rats learn the sensorimotor tasks faster than age-matched 
males, but following a stroke, age-matched males recovered better. We then sought to 
correlate these behavioral results with dendritic plasticity.18 month-old Fischer 344 male 
and female aged rats were divided into four groups: ovariectomized (OVX) females, 
intact females, sham OVX surgery males, and intact males. Pre-stroke, animals were 
trained in the skilled forelimb reaching task. The rats then underwent focal ischemic 
stroke via middle cerebral artery occlusion (MCAO) to affect the sensorimotor cortex 
associated with the preferred forelimb. Rats were then tested on the behavioral tests for 
eight weeks to assess post-stroke recovery, and then sacrificed for Golgi-Cox staining 
and dendritic characterization of contralateral pyramidal layer V motor neurons for 
complexity, length, number and the density of dendritic spines. Analysis of dendritic 
arborization showed that pre-stroke, intact females had the greatest number of dendrites 
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in the higher complexity levels whereas the OVX females had the lowest in the earlier 
complexity levels. Intact females also had the greatest length and number of dendrites 
whereas the OVX females had the lowest. OVX females had the lowest density of spines 
compared to all other groups. Post-stroke, all groups showed a decrease in complexity 
with the largest decrease seen in the intact female group. In conclusion, our results 
show that removing ovary-produced estradiol and related sex hormones results in less 
dendritic complexity, number, length and spine density in the pyramidal layer V motor 
cortex neurons in aged female rats.  
INTRODUCTION 
 Ischemic stroke is a prevalent cause of death and disability worldwide, with an 
increase in death and disability as age increases (Alkayed et al., 1999; Lewis et al., 
2012). Each year more than 795,000 people in the US have a stroke, with about 130,000 
resulting in death. (Bushnell et al., 2014). Recovery following stroke also shows a sex 
difference, with a pre-menopausal woman recovering better than an age-matched man, 
while following menopause the opposite is true (Bushnell et al., 2014). There have been 
many hypotheses for why this occurs, but the major cause seems to be the decrease in 
estradiol (and its related hormones, such as progesterone) that occurs during 
menopause (Bushnell, 2006; Bushnell, 2008). Estradiol has been found to not only be 
neuroprotective (Dang et al., 2011) but also useful in reducing apoptosis (Wu et al., 
2005), which the loss of estradiol potentially disrupting both of these mechanisms. 
 Of particular interest are the differences in stroke recovery observed between the 
sexes and the resulting difference in functional recovery observed. The Women’s Health 
Initiative (WHI) has set guidelines for use of female research animals to better 
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understand women’s health, which until now has been mainly focused on male animals 
(Bushnell et al., 2014). Thus a relevant animal model is necessary to evaluate post-
stroke recovery and any potential brain changes.  
 Based on these reported sex differences we examined the potential motor 
learning speed differences apparent in the aged rat, along with their resulting post-stroke 
functional recovery and the morphological changes in their pyramidal layer V forelimb 
motor cortex dendrites. Stroke has been shown before to decrease contralateral total 
dendritic length and complexity (Papadapoulos et al., 2002; Papadapoulos et al., 2006; 
Gillani et al., 2010) but has since only been looked at in male rats. Golgi stain was also 
used to show that estradiol increased spine density and dendrite length in the 
hippocampus (Brocca et al., 2013). An aged male rat study showed a motor recovery 
following stroke using anti-Nogo-A (Markus et al., 2005) but did not include females. 
Measurement of the speed of learning the skilled forelimb reaching task is novel to this 
study, along with the inclusion of intact female and OVX female groups. The inclusion of 
these new groups will allow for a clinically relevant study of aged stroke functional 
recovery and resulting dendritic morphology differences. 
METHODS 
All experimenters were blinded to rat group and treatment. 
Animal Subjects 
All animal experiments and protocols were approved by the Institutional Animal Care 
and Use Committee of the Hines Veterans Affairs Hospital in Hines, IL. A total of 73 
aged male and female Fischer 344 albino rats (18 months of age at start of the study) 
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were divided into four groups: normal males, sham ovariectomy (OVX) surgery males 
(anesthetized, flanks shaved, and skin/muscle walls cut before suturing together), 
normal (intact) females, and ovariectomized (OVX) females (Figure 43). Rats were 
housed two to a cage and were maintained in a 12 hour light/dark cycle with free access 
to water. Rats were food deprived to 95% of their body weight in order to encourage 
compliance with behavioral testing (Figure 41). 
RAT GROUPS AND NUMBERS 
 
Power analysis:  
For this aim, we started with a power analysis and incorporated eight experimental 
groups for comparison, setting alpha at 0.05.  A sample size of 72 (behavioral tests) and 
6 animals per group will be needed to achieve power of 0.8.  
 
 
 
 
 No Stroke Stroke  
Male 6 6  
Sham OVX Males 6 6  
Female 6 7  
OVX Female 6 6  
Total 36 37 73 
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Figure 41. Experimental Timeline of Aim 3. Rats will receive four weeks of behavioral 
training on the skilled forelimb reaching task and skilled ladder rung walking task before 
receiving a stroke to the hemisphere used for reaching. Post-stroke, rats will be tested 
for eight weeks on both behavioral tests before being sacrificed for Golgi-Cox histology. 
Ovariectomy (OVX) and Sham OVX Males 
Twelve females received an OVX in which both ovaries were removed. Rats were 
anesthetized using 2% isoflurane with oxygen and had both flanks shaved between the 
rib cage and pelvic bones. A one centimeter incision was made in the skin followed by a 
one centimeter incision in the underlying muscle wall. Ovaries were found by pulling 
underlying fat tissue and isolating the ovary. Oviducts were tied off and cut right below 
the ovary body. The muscles and skin were then sutured.  Some of the males received a 
‘sham OVX’ in which the flanks were shaved and the skin and muscle incisions made as 
above before being sutured. 
Estradiol Serum Measurements Via Enzyme-linked Immunosorbent Assay (ELISA) 
One week after ovariectomy all female rats had their tail vein blood collected for ELISA 
estradiol serum level determination. Tail blood was spun down and the serum was 
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collected then processed using Cayman Chemical’s Estradiol EIA Kit (Item 582251 Ann 
Arbor, MI). The kit’s detectable level for estradiol was 19pg/mL. 
Skilled Forelimb Reaching Task 
The skilled forelimb reaching task, as described in our previous studies (Papadopoulos 
et al., 2002; Markus et al., 2005; Tsai et al., 2007), was performed by all rats in a pre-
stroke training period (until baseline of 14 out of 20 pellet successes for three 
consecutive days) and a post-stroke testing period (for eight weeks following stroke). 
Rats were placed in a Plexiglas chamber (30 x 36 x 30 cm) with a rectangular opening 
(1.5 x 3 cm) with a Plexiglas shelf attached outside the opening.  Rats then learned to 
reach through the opening to grasp small sucrose pellets place on the shelf. The first 
week of testing involved two rats to a box at once then continue from then on as one rat 
per session. A success was defined as the rat reaching through the opening, grasping 
the pellet, and bringing it to its mouth. Rats were tested starting two days post-stroke. 
Rats were filmed at baseline and 1, 3 and 8 weeks post-stroke. 
Skilled Horizontal Ladder Rung Walking Task 
The rats’ accurate forelimb placement was examined by assessing the ability to cross a 
one-meter long runway of small bars with randomly assigned gaps as described by Metz 
(Metz & Whishaw, 2002).  Errors in foot placement of the stroke-impaired forelimb were 
analyzed (total number of errors/total number of steps) and the time to cross the grid 
was recorded. Latency was measured as the time it took rats to walk completely across 
the ladder. Rats were filmed at baseline and 1, 3 and 8 weeks post-stroke. 
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Stroke Surgery 
MCAO was performed as described in our previous work (Markus et al., 2005; Gillani et 
al., 2010). Animals were anesthetized (2-3% isoflurane in oxygen) and secured in a 
stereotaxic frame. An incision was made through the scalp and underlying muscle and 
the skull opened with a dental drill. The middle cerebral artery was then isolated and 
ligated by a 10-0 silk suture and transected with microscissors. Core body temperature 
was maintained at 37 degrees Celsius. The scalp was sutured closed and rats returned 
to their home cages. 
Perfusion for Golgi-Cox Staining and Reacting 
8 weeks after behavioral testing, rats were sacrificed and perfused with 0.9% saline. 
After extraction, brains sat in Golgi-Cox stain for two weeks (allowing for staining of a 
random group of neurons in their entirety) then were submerged in 30% sucrose until 
sinking. After sinking the brains were cut into 200um thick sections, placed on slides, 
and reacted by the modified Golgi-Cox method (Gibb and Kolb, 1998). Sections were 
placed in ammonium hydroxide for 30 minutes before being transferred to Kodak Fix 
Solution for 30 minutes. Sections were then dehydrated in increasing concentrations of 
ethanol before being placed in absolute ethanol for 15 minutes. Sections were then 
placed in a mixture of HemoDe, chloroform, and absolute ethanol before being placed in 
HemoDe. Sections were then coverslipped with permount and allowed to dry. Sections 
were examined for lesion size analysis and dendritic profile tracing in the contralesional 
forelimb motor cortex using Neurolucida. 
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Lesion Analysis 
The lesion volume was analyzed on alternate Golgi stained sections. The area of the 
intact contralateral hemisphere minus the area of the intact ipsilateral hemisphere was 
multiplied by the distance between sections. Area of stroke was expressed as a 
percentage of the intact contralateral hemispheric volume. 
Histological and Dendritic Analysis 
Basilar dendrites were traced at 630X magnification in the pyramidal layer V forelimb 
motor cortex and visual cortex layer II pyramidal neurons with the aid of Neurolucida 
software (Figure 42). Criteria for inclusion in the analyses is that the neuron has to be 
well impregnated with stain, unobstructed by other dendrites, blood vessels or glial cells, 
and the dendritic arborizations are intact and visible in the plane of section. For all 
analyses the slides were coded and investigators were blind to the treatment group.  
Twelve neurons from each animal were traced. Dendritic trees were analyzed for total 
dendritic length and total number of branch order. Branch order was determined by 
considering that branches emanating directly from the cell body are first order; once 
bifurcation occurs, two secondary dendrites are formed and so on. Corresponding 
procedures were performed in the occipital cortex as a control measurement. Dendritic 
spine densities were analyzed by counting visible spines along a measured 50um 
section of dendrite (starting at the soma). Spine density was expressed as the number of 
spines per 10 μm. 
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Figure 42. Golgi-Cox Stain. Representative photomicrographs of neurons stained by 
Golgi-Cox in the contralesional forelimb motor cortex. Note the defined dendrites and 
spines visualized by the stain, which through a heavy metal makes the neuron dark. 
Scale bar 10 um. 
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Statistical Analysis 
All data analysis was performed with GraphPad Prism Version 6.0 software (La Jolla, CA 
USA) for repeated-measures ANOVA and one-way ANOVA with Tukey post-hoc tests or 
SPSS (IBM, Armonk, NY, USA) for F statistics.  
The main effect of group, main effect of week, and Group x Week (reported as F value) 
were used. Afterwards, a repeated-measures ANOVA was used to compare the rate of 
improvement and learning on the behavioral tasks and a one-way ANOVA with Tukey’s 
post hoc analysis was used to compare the mean of success scores, the Golgi-Cox data 
and lesion analysis data. A p value less than or equal to 0.05 was considered significant. 
RESULTS 
Behavioral Data 
Skilled Forelimb Reaching Task 
Pre-stroke, there was a significant sex difference in learning the task over four weeks, 
with males learning the task significantly slower than both female groups (Figure 43). A 
group difference [F(3, 66) = 31.22, p < 0.05], week difference [F(2, 22) = 17.49, p < 0.05] 
and Group x Week difference [F(6, 66) = 50.03, p < 0.05] were seen. There was no 
significant difference between the intact and OVX female. Both male groups were 
significantly slower than both female groups at weeks two and three. Both male groups 
also had significantly lower successful reach percentages at weeks two and three. 
However, all groups were able to attain the same number of pellets by four weeks of 
training, with no significant difference between groups at that point (Figure 44). There 
was a slight majority of left-handed rats over right-handed, but this was equally spread 
amongst all groups. 
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The F test conducted revealed significant differences by group [F(3, 66) = 66.42, p < 
0.05], week [F(2, 22) = 13.58, p < 0.05], and Group x Week [F(6, 66) = 52.17, p < 0.05] 
for post-stroke recovery. Post-stroke, there was also a sex difference in functional 
recovery of pellet success scores, with OVX females performing the worst over 8 weeks 
following stroke while intact females were slightly and significantly better (Figure 43). A 
significant difference of week for OVX females at weeks 5, 6, 7 and 8 was revealed. 
Both male groups reached successfully significantly more at all time points, with intact 
females reaching significantly better than OVX females at weeks five through eight.  
Both female groups had significantly lower successful reach percentages at weeks two, 
three, and four. There was no significant difference between groups from week five 
onwards for group, where males continued to reach successfully at around 50% while 
both female groups improved their reach percentages. Although both female groups 
improved their reach percentages, the total successful reaches remained significantly 
lower than both male groups (Figure 45). 
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Figure 43. Skilled forelimb reaching task in the aged rat. (A) Rat reaching for pellet. 
(B) Successes pre-stroke and (C) post-stroke. Intact females and OVX females learn 
faster than males pre-stroke but have slower recovery post-stroke. * = p < 0.05 
(Repeated Measures ANOVA with Tukey Post-Hoc) comparing both male groups 
against both female groups. # = p < 0.05 (Repeated Measures ANOVA with Tukey Post-
Hoc) comparing OVX females against all groups. Error bars: standard error of the mean.  
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Figure 44. Reaching Percentages Pre-stroke. Percentages of successful reaches 
during the pre-stroke learning phase. Males had significantly lower success percentages 
than females during weeks two and three. Error bars represent standard error of the 
mean. * signifies p < 0.05, ** signifies p < 0.01 (One-way ANOVA with Bonferroni post 
hoc test) compared with female groups. 
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Figure 45. Reaching Percentages Post-stroke. Percentages of successful reaches 
during the post-stroke phase. Males had significantly higher success percentages than 
females during weeks one through four. Error bars represent standard error of the mean. 
* signifies p < 0.05, ** signifies p < 0.01 (One-way ANOVA with Bonferroni post hoc test). 
Skilled Ladder Rung Walking Task 
Pre-stroke, there was a group difference in learning the task over four weeks, with OVX 
females performing the worst (most number of forelimb slips) compared to both male 
groups and the intact females (Figure 46). This was seen in group differences [F(3, 66) = 
60.89, p < 0.05]), and week differences [F(2,22) = 17.22, p < 0.05], and Group x Week 
[F(6,66) = 44.65, p < 0.05]. At weeks one, two, and three a significant difference was 
seen between female OVX rats and all other groups. However, by four weeks of training, 
all groups had achieved the same number of slips, with no significant difference between 
groups. There were no significant differences between groups for latency (time it took to 
cross the ladder) in speed for crossing the barwalk (Figure 47) for group [F(3, 66) = 
15.67, p = .77] or week [F(2, 22) = 10.33, p = .62]. 
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Post-stroke, there was a sex difference between the males and female groups, with the 
males performing better (lower number of forelimb slips) than both female groups (no 
significant difference between the female groups) (Figure 46). The F test conducted 
revealed significant group differences [F(3, 66) = 62.54, p < 0.05], week differences [F(2, 
22) = 14.88, p < 0.05], and Group x Week differences [F(6, 66) = 52.31, p < 0.05]. There 
was a significant difference at all time points between the male groups and the female 
groups. There were no significant differences between groups for latency in speed for 
crossing the barwalk at each time period (Figure 48) for group [F(3, 66) = 18.89, p = .56] 
or week [F(2, 22) = 10.13, p = .68]. 
Lesion Analysis 
Lesion analysis of the stroke brains revealed no significant difference in lesion size 
between groups (Figure 50). 
Weight 
There was a difference in weights between males and females, however no significant 
weight loss was seen (Figure 49). 
Golgi-Cox Dendritic Profiles 
The dendritic profiles revealed that pre-stroke, intact females had the highest complexity, 
total branch number and lengths (Figures 51 through 53). OVX females had the lowest 
complexity, total branch number and lengths, and also had the lowest spine density 
(Figure 56). There were no significant group differences in the primary visual cortex for 
complexity, branch length, and spine density (Figures 55 and 56). 
Post-stroke, males had the highest dendritic complexity for the primary and secondary 
dendrites (Figure 57). At the third dendrite complexity onwards, there were no significant 
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differences between groups. Males had the longest lengths (Figure 58) and highest 
spine density (Figure 59). 
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Figure 46. Walking task. Rat performing  task (A), Pre-stroke average number of 
weekly falls per 10 steps (B), Post-stroke average number of weekly falls per 10 steps 
(C). * p < 0.05, ** p < 0.01. (Repeated Measures ANOVA, Tukey Post-Hoc Test) 
compared to all groups (A) and to both female groups (B). Error bars: standard error of 
the mean. 
 
  
Figure 47. Pre-stroke Latency. Latency in seconds for the pre-stroke learning portion 
of the skilled ladder rung walking task. There was no significant time difference between 
groups. Error bars represent standard error of the mean. 
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Figure 48. Post-stroke latency. Latency in seconds for the skilled ladder rung walking 
task during the post-stroke phase. There was no significant time difference between 
groups. Error bars represent standard error of the mean. 
 
 
Figure 49. Weight Changes in Aim 3. Weight changes (in grams) over the four week 
learning period are not significantly different between weeks 0 and 4, although males 
weighed significantly more than females. 
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Figure 50. Lesion analysis (Aim 3). (A) TTC (2,3,5-triphenyl-2H-tetrazolium chloride)-
stained coronal brain sections of an aged male rat at 2 days after MCAO demonstrates a 
representative stroke size and location in the ispilateral sensorimotor cortex. Viable 
tissue appears red and the area of the ischemic infarction appears white. (B) Lesion 
analysis showed no difference in stroke size between aged male, aged female, and 
aged female/ovariectomized (OVX) rats. (p>0.05). TTC photo courtesy of DJ Shepherd. 
Error bars represent standard deviation. 
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Figure 51. Pre-stroke neuronal dendritic complexity showing branch order of 
forelimb sensorimotor cortex corresponding to the preferred forelimb (A) and the 
opposite motor cortex (B). (* p < 0.05). Error bars represent standard error of the mean. 
 
 
Figure 52. Pre-stroke neuronal dendritic total branch number (* p < 0.05). Error bars 
represent standard error of the mean. 
 
* * 
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Figure 53. Pre-stroke neuronal dendritic total branch length (* p < 0.05). Error bars 
represent standard error of the mean. 
 
 
 
Figure 54. Dendritic spine density of neurons pre-stroke (n=12 neurons per animal) 
in the forelimb sensorimotor cortex corresponding to the preferred forelimb (A) and 
opposite cortex (A’). Representative Golgi-Cox stained images of spines in the different 
groups: male (B), male sham (C), intact female (D), and OVX female (E). * p < 0.05. 
Error bars represent +/- SEM. (One-way ANOVA, Bonferroni post hoc).  Bar indicates 
1um. Error bars represent standard error of the mean. 
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Figure 55: Pre-stroke neuronal dendritic complexity (visual cortex). Branch order of 
primary visual cortex corresponding to the preferred forelimb (A) and the opposite motor 
cortex (B). No significance was detected. Error bars represent standard error of the 
mean. 
 
 
Figure 56. Pre-stroke number of dendrites and length in the primary visual cortex 
corresponding to the preferred forelimb (A,C) and the opposite motor cortex (B,D). No 
significance was detected. Error bars represent standard error of the mean. 
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Figure 57. Post-stroke neuronal dendritic complexity showing branch order of 
contralesional forelimb sensorimotor cortex (* p < 0.05). Error bars represent standard 
error of the mean. 
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Figure 58. Post-stroke neuronal dendritic length of forelimb sensorimotor cortex 
contralesional sensorimotor cortex (* p < 0.05). Error bars represent standard error of 
the mean. 
 
 
Figure 59. Post-stroke dendritic spine density of neurons in the contralesional 
forelimb sensorimotor cortex (* p < 0.05). Error bars represent standard error of the 
mean. 
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DISCUSSION 
The results from this study show that sex differences exist in aged rats when examining 
both the training period to learn a task, as well as the post-stroke recovery period for that 
task. Specifically, for the forelimb reaching task, both groups of females learned skilled 
reaching faster than the males. For the skilled walking task, OVX females took the 
longest time to learn the test. Interestingly, post-stroke recovery was worse for both 
female groups as compared to males for both tasks. Golgi analysis from pyramidal 
neurons in the contralesional cortex correlated with these post-stroke behavioral results, 
with both females groups having less dendritic complexity and spine density (Figure 54) 
when compared to males post-stroke. 
These results show that there exists a sex difference in learning skilled motor tasks, one 
involving skilled reaching and the other skilled walking. Various reasons have been put 
forth to explain the underlying mechanism for such sex differences, including differences 
in encoding learning engrams (behavioral patterns useful to the animal) (Monfils et al., 
2005; Wallace et al., 2012) or differences in body positioning during the task (Field and 
Whishaw, 2005). The damage to this engram during brain injury could be believed to 
impact post-stroke recovery as the engram needs to be reformed or formed elsewhere in 
the brain (Whishaw, 2000; Wallace et al., 2012). Learning differences may be due to the 
significant difference in body weight between males and females (Figure 51). 
Of interesting note is the fast learning speed in both tasks by the intact females, while 
OVX females were not as fast to learn the skilled ladder rung walking task. Males were 
slowest to learn the skilled forelimb reaching task yet were fast to learn the skilled ladder 
rung walking task. These tasks are very different in what they measure and the 
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differences described above could be attributed to that. The skilled forelimb reaching 
task is considered a very fine task of upper extremity function, while the skilled ladder 
rung walking task involves far more body movements. Both require the rat to balance 
and make fine forelimb movements, which serve to accurately measure post-stroke 
functional recovery. Different brain pathways are responsible, yet both require the 
forelimb motor cortex in order to function properly (Whishaw, 2000; Metz and Whishaw, 
2002; Metz and Whishaw, 2009; Alaverdashvili and Whishaw, 2010). The body weights 
of the rats could also be a factor (Figure 51), as the males may have a better ability to 
balance with a larger body. Males may also have a longer stride than females based on 
this larger size. 
Post-stroke sex differences in functional motor recovery are dependent on relating motor 
cortex damage to the behavior in question along with any possible repair or plasticity 
(Whishaw et al., 2008). The sex differences observed in post-stroke behavioral analysis 
correlate to the human post-stroke clinical data in which older women do not recover 
from stroke as well as men (Bushnell et al., 2014). There are several proposed reasons 
for why this is the case. One theory is that estradiol has been neuroprotective throughout 
the entire reproductive life of the female and its removal during menopause (or lowering 
to a low constant level in rats) may render the neurons who have since relied upon it 
very ‘fragile’ and susceptible to cell death or dysfunction. Men (although not male rats) 
undergo ‘Andropause’ in which testosterone is secreted at lower levels than normal, but 
a detectable level still remains and may act as a neuro-protectant either as testosterone 
or aromatized to estradiol. It is speculated that testosterone may have a strong 
neuroprotective effect in male rats as their post-stroke recovery was higher than both 
female groups. This could corroborate with literature in which testosterone is seen to be 
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very pro-growth and positively modulates dendrites and spines (Chen et al., 2013; Wu 
and Gore, 2010). 
The lack of significant difference in lesion size is believed to be due to consistent 
technique as well as lack of neuroprotection by neurosteroids at this old age. At young 
adult age (8 weeks), exogenous estradiol was shown to reduce infarct sizes in both male 
and OVX female rats (Dang et al., 2011). 
Sex differences in regard to Golgi-Cox dendritic analysis yielded results somewhat 
consistent with the behavioral results. Pre-stroke, intact females were found to have the 
highest dendritic complexity, males the next highest, with OVX females having the 
lowest complexity. While for intact females this correlates to the skilled forelimb reaching 
and skilled ladder rung walking tasks, it does not explain why OVX females learned the 
skilled forelimb reaching task quickly but not the skilled ladder rung walking task. It also 
does not correlate with the male behavioral task performance. Males were shown to still 
have high testosterone levels, and this pro-growth hormone may have a beneficial effect 
in recovery and excitatory synapse number, but not in learning. 
The pre-stroke spine data corroborates earlier literature in which estradiol increases 
spine number (Foy et al., 2008) but does not correlate to the different group 
performances in learning pre-stroke. It is also believed that sex hormone levels will not 
change drastically over this testing period, which could have impacted recovery. 
The secondary visual cortex data is similar to what was hypothesized and no group 
differences are seen in dendritic complexity, length, or dendrite number. This area has 
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previously acted as an internal control for examining dendritic differences 
(Papadapoulos et al., 2002; Gillani et al., 2010). 
Post-stroke Golgi-Cox profiles do tend to correlate well with the post-stroke behavioral 
data. Intact and OVX females had the lowest dendritic complexity post-stroke and this 
correlates with the skilled forelimb reaching task and skilled ladder rung walking task. 
Intact females had the largest drop in complexity following stroke while males did not. All 
groups had a resulting drop in complexity and spine density following stroke. OVX 
females remained the lowest spine density following stroke, again following previous 
reports in which estradiol has been shown to increase spine number (Foy et al., 2008). 
In instances in which the dendritic profile data does not correlate with the observed 
behavioral data, it is proposed that other factors may play a role than simply the number 
of dendrites or spines.  We only looked at a single region responsible for motor 
movements, despite that region being the area that is affected by middle cerebral artery 
occlusion stroke and its resulting behavioral deficits. In other brain regions 
(supplementary motor cortex or cerebellum) a difference may be seen. This reasoning is 
further examined in the next chapter which seeks to better characterize neural 
communication and show a more detailed and molecular approach to determining cortex 
connectivity.  
In conclusion, it has been shown here that while both female groups learned faster (in 
the skilled reaching task), males had better post-stroke recovery (in both tasks). There 
were correlates in the Golgi-Cox data, in which pre-stroke females had the greatest 
dendritic complexity and length, but OVX females had the lowest density of dendritic 
spines. Post-stroke males had the highest dendritic complexity and dendritic length. It 
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has been shown here that ovariectomy reduces dendritic complexity, length, and spine 
density.
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CHAPTER SIX 
GENERAL DISCUSSION 
The results from this dissertation show that there exists a sex difference in motor 
learning (aged females learned the skilled forelimb reaching task faster than males) and 
post-stroke motor recovery (both female groups had lower functional recovery in both 
behavioral tasks), and that morphological differences exist in terms of dendrite length, 
number and spine number (pre-stroke, intact females have the most complexity, length, 
and spine density, but post-stroke males have the most of all of these parameters). 
There are group differences with regard to excitatory synapse numbers (OVX females 
have the lowest amount of synapses at eight weeks). Furthermore, stroke reduced 
synapse number at eight weeks in both intact females and males but not OVX females. 
It has also been shown that anti-Nogo-A immunotherapy given post-stroke increases the 
synaptic numbers in aged male and intact female groups, but not OVX female group. 
Aim 1 sought to look at the number of excitatory connections synapsing on pyramidal 
neurons in the forelimb motor cortex. Through specific markers (VGLUT1 for cortico-
cortical excitatory connections and VGLUT 2 for thalamo-cortical excitatory connections) 
the numbers of synapses were quantified at 3 and 8 weeks in stroke and non-stroke 
rats. This revealed group differences especially at the eight week time point, with 
decreases seen following stroke. This is expected due to the fact that the synapses will 
be lost that communicated with parts of the infarct hemisphere. Intact females did not 
see a significant drop following stroke (VGLUT2) and this is postulated to be due to 
continued strong thalamic communication with the forelimb motor cortex. 
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Aim 2 further examined the synaptic proteins looked at in Aim 1 with the added 
treatment of 11C7 immediately after stroke (anti-Nogo-A immunotherapy) and examining 
the synaptic changes at 3 weeks. It was found that males and intact females had 
increases in both VGLUT1 and VGLUT2 number following anti-Nogo-A immunotherapy 
and this was not seen in OVX females. This showed a sex hormone difference in 
response to 11C7, with only intact females and males having a significant increase in 
synapse number. 
Aim 3 examined behavioral learning pre-stroke and functional recovery post-stroke, 
along with Golgi-Cox dendritic analysis. It was shown that while males were the slowest 
group to reach baseline in the skilled forelimb reaching task, they had the best functional 
recovery post-stroke. While intact females had the highest dendritic complexity pre-
stroke, this was reduced below males post-stroke. OVX females had the worst dendritic 
profile pre-stroke and this continued on into post-stroke, including the lowest spine 
density. 
Our lab has a long history of studying functional recovery after stroke and possible 
therapeutic interventions that may aid recovery. There is, however, an important gap in 
our knowledge concerning therapeutic interventions and their effect on aged females. 
Aged OVX females are a suitable model for studying post-menopausal women, as 
shown by the undetectable estradiol levels and the poor functional recovery following 
stroke. Behaviorally we have shown that following stroke, OVX females have 
significantly lower functional recovery than all other groups in the skilled forelimb 
reaching task and lower functional recovery than the male groups in the skilled ladder 
rung walking task. In this model we also saw significantly lower pre-stroke dendritic 
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complexity, dendritic length, and spine density. These low values were also seen post-
stroke. 
The behavioral effects seen here could be attributed to the sex of the investigator, which 
has been shown to affect rat behavior and stress levels. It is believed that these results 
should be followed up with an investigator of the opposite sex to corroborate. 
Strain is also a potential variant in interpretation of these results. The Fischer 344 strain 
is a common aged rat model and as such was chosen for this study. Other rat strains are 
available, such as Long-Evanns (black-hooded) rats. Strains could have differences in 
cognition, behavioral results, and dendritic morphology. 
The complex interactions between sex hormones, synaptic proteins, and growth 
inhibitory molecules like Nogo-A form a complicated pathway that requires more 
research to understand. We have found that anti-Nogo-A immunotherapy does increase 
excitatory synaptic number in aged male and intact female rats, but not OVX rats. This 
could mean that an almost zero level of estradiol (as in the OVX females) is not sufficient 
to increase synapse number, even in the absence of a major growth inhibitory molecule. 
It is not suggested that estradiol is required for increased excitatory synaptic number 
following 11C7, although it may play a large role in increasing connections after 
immunotherapy. Male rats have significant levels of testosterone, which has been shown 
to be pro-dendritic and pro-growth (Dubal and Wise, 2001; Etgen et al., 2011; Chen et 
al., 2013) and can be aromatized to estradiol. 
Presented here is a link between forelimb motor cortex dendritic morphology (in terms of 
length, complexity, and spine number) and behavioral learning and post-stroke motor 
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recovery. Pre-stroke, intact females had longer dendrites and this correlates well to their 
faster learning speed. OVX females had a decreased number of spines, yet still had a 
fast learning speed compared to males (who were slow to learn and had a dendritic 
complexity less than intact females but greater than the OVX females). 
Males had the best motor recovery following stroke as compared to intact females and 
OVX females. This did correlate with the dendritic complexity data in which males post-
stroke had a very small drop while intact females and OVX females had a large 
decrease in complexity. These results may be useful as a clinical model as this 
correlates with the outcome for functional recovery in the aged population following 
stroke. This morphological data can be compared to Aim 1 in which the specific synaptic 
protein changes and locations could be examined in the forelimb motor cortex. Aim 
1showed that males had a large drop in excitatory synapses following stroke at eight 
weeks, seen also with VGLUT1 and intact females. This does not correlate with the 
males’ better functional recovery while it did correlate with the intact females (poor post-
stroke behavioral recovery). The low number of post-stroke excitatory synapses in OVX 
females does correlate with their poor post-stroke recovery, but not with their fast pre-
stroke learning. While some of the parts of the above aims correlate, there are parts that 
do not correlate. The parts that do not correlate could be explained by looking at a 
different brain region or cortex layer (as the examine layer V pyramidal cells did not 
show a difference). There may also be a change seen on the apical dendrites instead, 
whereas only the basilar were examined here. 
There was some data that did not fit as neatly, however. When comparing the Aim 3 
dendritic complexity of OVX females, it did not correlate to the learning speed of the 
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skilled reaching task (they have less dendritic complexity but learned the task quickly), 
but did seem to correlate to the skilled ladder rung walking task (in which they did poorly 
post-stroke). The VGLUT2 synapse numbers of intact females showed no significant 
decrease, and yet intact females did not recover well for both post-stroke behavioral 
tasks and had a decrease in dendritic complexity (it did correlate for OVX females, 
however). These differences in expected correlations can be explained by the scope of 
the study. Only a specific brain region was studied, and as such it is believed that there 
may be a change in the brain elsewhere that can explain these behavioral changes. 
Different cell types could also be studied in these regions to explain these differences. 
The signaling mechanisms used by Nogo-A to exert its growth inhibition have shown that 
a downstream target is CREB, which through ROCK it causes to be dephosphorylated 
(and lowers its activity) (Schmandke et al., 2014). CREB is also a target of estradiol 
signaling (Wu et al., 2005), which it phosphorylates through protein kinase A. This 
potential interaction could explain the results of Aim 2, in which OVX females did not 
respond to anti-Nogo-A immunotherapy. Even the low level of endogenous sex 
hormones in the intact female group could have a positive benefit to the animal through 
CREB phosphorylation. CREB acts as a transcription factor to upregulate expression of 
many synaptic proteins, including the NMDA receptor (Wu et al., 2005). As this was the 
post-synaptic protein studied in Aims 1 and 2, this could explain why excitatory synapses 
were found to be low in OVX females, both pre- and post-stroke (Figure 61). 
The above show the impact of anti-Nogo-A immunotherapy on synaptic number and its 
possible mechanistic pathways alongside estradiol signaling. Taken together, a cohesive 
picture of sex differences in the aged rat model behavior (learning and recovery) 
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alongside dendritic morphology and synaptic protein differences emerges. Treatment 
with anti-Nogo-A also showed changes in synaptic proteins, shown by Aim 3. Overall, 
OVX females were found to have lower dendritic number, spines, dendritic complexity 
and a lack of increase in VGLUT following 11C7. The removal of estradiol and related 
sex hormones via ovariectomy seems to pose a large problem at the cellular neuron 
level as well as behaviorally in terms of functional recovery following stroke (Aim 1). 
Removal of estradiol has been shown here to have many negative effects at the 
neuronal level which also translate to behavior (Aim 1). Sex differences are also very 
apparent here, with the apparent benefits of having estradiol and its related sex 
hormones (Summarized in figure 62). 
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Figure 60. Summary of all results. Pre-, post- and post-stroke with anti-Nogo-A 
effects chart. 
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Figure 61. Summary of Sex Hormone and Nogo-A interaction.  The intersection of 
sex hormone signaling such as estradiol with Nogo-A’s growth inhibitory cascade is 
believed to be at CREB. Estradiol increases CREB phosphorylation (Wu et al., 2005) 
while Nogo-A dephosphorylates it (Schmandke et al., 2013). CREB, when 
phosphorylated, is an active transcription factor responsible for increasing expression of 
anti-apoptotic genes such as Bcl-2 and proteins used in new synapses. 
 
 
 
 
 
125 
 
 
FUTURE DIRECTIONS 
It is proposed for future directions that this work be continued in a manner as to 
ascertain the underlying mechanisms of sex differences. One proposal is the use of 
hormone replacement therapy (HRT) translated into the rat model in which exogenous 
estradiol is placed in a capsule form subcutaneously to mimic the HRT that women may 
receive. This is believed to be an acceptable replacement for the estrogen loss from 
OVX.  The literature is filled with reports on hormone therapy (Nelson et al., 2012; Wise, 
2015) and a large debate continues over dosage, timing, usage of estrogen, 
progesterone (Paris et al., 2011), or both as well as potential benefits or health risks 
(Wassertheil-Smoller, 2010; Wise, 2015), as complications can arise from estrogen or 
other sex hormone therapy, such as risks for cancer and cardiovascular effects 
(Goodrow et al., 2005). An even further direction can be to use the aged rat stroke 
model to examine the different HRT types, such as conjugated equine estrogens and 
others. Gonadectomized male rats are also proposed to see the effects of removing 
testosterone on post-stroke behavior and synaptic changes. 
Another proposal is for the quantification of Nogo-A and other growth inhibitory proteins 
in the aged rat brain (as well as specifically the forelimb motor cortex) in order to 
determine if sex differences exist in the levels of Nogo-A, Nogo-A receptors, OMgp, 
MAG, and PirB. This could add a mechanistic approach to determining differences in 
pre-stroke motor learning as well as post-stroke functional recovery. Western blotting 
using either whole brain homogenates or dissected homogenized motor cortices is 
proposed for this, along with protein quantification of the proteins of interest mentioned 
in this study: VGLUT1 and 2, NMDAR, AMPAR, BDNF, the estrogen receptors, and 
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other synaptic proteins. Localization of the estrogen receptors, while already looked at, 
has not yet been looked at in aged or OVX rats. 
A further proposal is the use of an enriched environment and rat therapy and 
rehabilitation to measure potential changes in functional motor recovery and dendritic 
plasticity and synaptic connectivity. An enriched environment has been shown to be 
helpful for motor recovery (Janssen et al., 2010). Combination with the above and HRT 
is also proposed, along with combination with 11C7 treatment. 
Further exploration of synaptic connectivity proteins is another possibility. Explored in 
depth here were excitatory connections, but inhibitory connections remains a possibility, 
as well as further classification of cortical connectivity to areas of interest such as the 
sensorimotor cortex and its individual layers, the basal ganglia, the red nucleus, and the 
spinal cord. 
For a mechanistic future direction, it is proposed that the relevant pathway for Nogo 
signaling (RhoA) could be better understood, along with the interaction that this same 
pathway has with estradiol and BDNF/TrkB signaling (Kramar et al., 2013). Manipulation 
of these three important pathways and their relevance to neuroplasticity are currently not 
well understood and the effects of the three ligands on the same pathway are proposed 
to be better studied in the future. 
Finally, it is proposed that altering the post-stroke treatment and observation times may 
shed more light on functional recovery and effects of timing of the immunotherapy. In the 
past delayed treatment has been used (such as a six month delay for beginning 
immunotherapy). Proposed here is a longer immunotherapy session (three weeks or 
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more) as well as carrying out post-stroke behavioral testing until 15 weeks or more 
before sacrifice. This could reveal any further potential functional recovery if the rats 
have not completely plateaued and provide a more accurate clinical model in which long 
delayed recovery could occur. Behavioral analysis of post-stroke aged intact and OVX 
females with antibody treatment is also a future direction, as well as usage of 
gonadectomized males. 
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